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Die Mitglieder der EGR Familie gehören zur Gruppe der ‚Immediate Early Genes‘,
die durch unterschiedliche Stimuli in verschiedenen Zellen des Immunsystems
induziert werden. Die EGR Proteine werden direkt und transient aktiviert durch
mitogene Stimulation und sie verbinden frühe zelluläre Ereignisse mit den
langfristigen Veränderungen der Zellantwort. Die EGR-Proteine kooperieren mit
anderen Transkriptionfaktoren im Zellkern und regulieren die Expression
verschiedener inflammatorischer Zytokine, wie IL-2, TNFα und ICAM-1. Das Ziel
dieser Arbeit war es, die Funktion von EGR-2 zu charakterisieren und die Rolle von
EGR-2/NF-κB-, EGR-2/NAB- und EGR/EGR-Komplexen bei der TNFα- und ICAM-1-
Gentranskription aufzuklären.
Schon nach dreistündiger Stimulation mit PHA/PMA wird EGR-2 in Jurkat T-Zellen
exprimiert. Rekombinantes EGR-2 wurde im Baculovirus-System überexprimiert und
zeigte eine ähnliche Mobilität wie das native Protein (55 kDa). Auf Grund des
Histidin-Tags konnte das Protein durch Ni-Chelat-Chromatographie aufgereinigt
werden. Mittels konfokaler “Laser-Scanning-Mikroskopie” konnte eine überwiegend
zytoplasmatische Lokalisierung von EGR-2 in unstimulierten Jurkat T-Zellen gezeigt
werden. Nach Stimulierung der Jurkat T-Zellen war EGR-2 im Nukleus nachweisbar.
Die Proteine der NF-κB-Familie wurden als native und rekombinante Proteine in E.
coli exprimiert.
EGR-2 geht physikalische und funktionelle Komplexe mit den Mitgliedern der NF-κB-
Familie ein. Die Bindung von EGR-2 mit p50 und p65 wurde im ‚Pull-down‘-Assay mit
nativen und rekombinanten Proteinen gezeigt. Diese Interaktionen konnten in in-vivo
FRET-Analysen bestätigt werden. Die FRET-Signale wurden im Zytoplasma sowie im
Zellkern detektiert, was auf einen Energietransfer von NF-κBCFP zu EGR-2YFP
schliessen lässt. Transfektionsstudien zeigten eine stark synergistische Interaktion
zwischen EGR-2 und p65 am TNFα- und am ICAM-1-Promotor. Im Gegensatz dazu
hat EGR-2 allein oder in Kombination mit p50 einen geringen Effekt auf die
Transkription. Im Vergleich der EGR-1/p65-, EGR-3/p65- und EGR-4/p65-
Heterodimere konnte durch EGR-2/p65 die stärkste Aktivierung (178-fache Induktion)
des TNFα-Promotors detektiert werden. Alle EGR-/p65 Komplexe übertrafen die
Zusammenfassung
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p50/p65 Hetero- und p65-Homodimere in ihrer Fähigkeit, den TNFα- und ICAM-1-
Promotor zu aktivieren. Daraus läßt sich eine bedeutende Rolle der EGR-Proteine für
die Induktion der Transkription dieser Zytokine ableiten.
Das EGR-2 Protein geht physikalische Interaktionen mit noch weiteren nukleären
Proteinen ein, z.B. dem transkriptionalen Repressorprotein NAB-2. Diese Bindung
konnte in ‚Pull-down‘-Assays, Co-immunopräzipitationen und in FRET-Analysen
gezeigt werden. Transfektionsstudien zeigten, dass NAB-1 und NAB-2 die EGR-
2/p65-vermittelte Aktivierung der TNFα- und ICAM-1-Zytokine inhibieren. Die
synergistische Aktivität von EGR-1/p65-, EGR-3/p65- und EGR-4/p65-Komplexen bei
der transkriptionalen Aktivierung der TNFα- und ICAM-1-Genen wurde ebenfalls
durch die NAB-Proteine gestört. Folglich sind NAB-Proteine Repressoren der EGR-
/p65 vermittelten Aktivierung der TNFα- und ICAM-1-Genexpression.
EGR-4-Domänen, welche für die Bindung das NAB-2 Proteins verantwortlich sind,
konnten in Transfektionsstudien mittels verschiedener Deletionsmutanten identifiziert
werden. Das NAB-2-Protein inhibierte die Aktivität aller analysierten EGR-4-
Mutanten. Außerdem reprimieren die NAB-Proteine die transkriptionale Aktivität von
p65 alleine. Zusätzlich konnte die Bildung von NAB-2/EGR-4- und NAB-2/p65-
Komplexen in vivo mittels FRET-Analysen gezeigt werden. Die EGR-4/NAB-2-
Interaktion konnte ebenfalls in ‚Pull-down‘ Assays nachgewiesen werden.
Diese Ergebnisse lassen darauf schließen, dass NAB-2 die Interaktion zwischen
EGR-4 und p65 durch die Bindung an beide Proteine inhibiert.
EGR-Proteine interagieren nicht nur mit unterschiedlichen Transkriptionfaktoren
sondern sie gehen untereinander Bindungen in Form von Heterodimeren ein. Die
EGR-EGR-Interaktion wurde in ‚Pull-down‘-Assays gezeigt und durch FRET-
Experimente verifiziert.
Unter Berücksichtigung der Tatsache, dass diese Heterodimere bei der TNFα- und
ICAM-1-Transkription nicht aktiv sind, können sie für die Stabilisierung der einzelnen




EGR family members belong to the group of immediate early genes, that are
stimulated by various stimuli in diverse cells of immune system. EGR proteins are
activated rapidly and transiently upon mitogenic stimulation, and couple early cellular
signaling events with long term changes in cellular response. EGR proteins
cooperate with other transcription factors in the nucleus and regulate expression of
various inflammatory cytokines, like IL-2, TNFα and ICAM-1. The aim of this work is
to characterize the function of EGR-2 protein and elucidate the role EGR-2/NF-κB,
EGR-2/NAB and EGR/EGR complexes in TNFα and ICAM-1 gene transcription.
EGR-2 protein expression is detected as early as 3 hours after PHA/PMA stimulation
in Jurkat T cells. Recombinant EGR-2, overexpressed in Baculovirus system,
showed the similar mobility as endogenous protein (55 kDa), and due to the histidine
tag the protein was purified by nickel chelate chromatography. Confocal fluorescence
microscopy showed in unstimulated Jurkat T cells predominant cytoplasmic
localization of EGR-2, and upon stimulation the protein translocates to the nucleus,
where transcriptional regulation takes place. Proteins of NF-κB family were
expressed as endogenous and as recombinant proteins in E. coli.
EGR-2 forms physical and functional complexes with members of NF-κB family.
Physical interactions of EGR-2 with p50 and p65 proteins were demonstrated in ‘pull-
down’ assays, with both native and recombinant proteins. These interactions were
confirmed by in vivo FRET analysis. A FRET signal was detected in both cytoplasm
and nucleus, thus indicating energy transfer from NF-κBCFP donor to EGR-2YFP
acceptor proteins that are present in close proximity. Transfection assays show
strong synergistic interaction between EGR-2 and p65 proteins in TNFα and ICAM-1
transcriptional regulation. In contrast, EGR-2 alone or in combination with p50 NF-κB
had little effect on transcription. In comparison with EGR-1/p65, EGR-3/p65 and
EGR-4/p65 heterodimers, EGR-2/p65 showed the strongest potency (178-fold
induction) in activation of TNFa promoter. All EGR-/p65 complexes exceed p50/p65
hetero- and p65 homodimers in activation of TNFa and ICAM-1 inflammatory genes,
thus confirming a role of EGR proteins in transcriptional induction of these cytokines.
EGR-2 protein physically interacts with an additional nuclear protein, the
transcriptional repressor NAB-2. This interaction was shown in ‘pull-down’ assays,
Summary
X
co-immunoprecipitation and FRET analysis. In transfection assays NAB-1 and NAB-2
proteins abrogated EGR-2/p65 mediated activation of TNFa and ICAM-1 cytokines.
Synergistic activity of EGR-1/p65, EGR-3/p65 and EGR-4/p65 complexes in
transcriptional activation of TNFa and ICAM-1 genes was also abrogated upon
expression of NAB proteins. NAB proteins therefore act as repressors of EGR-/p65
mediated activation of TNFa and ICAM-1 genes.
Identification of EGR-4 domains responsible for NAB-2 protein binding was
investigated in transfection assays using various deletion mutants. NAB-2 protein
repressed the activity of all analyzed mutant EGR-4. NAB proteins also repress the
transcriptional activity of p65 protein alone. Additionally, NAB-2/EGR-4 and NAB-
2/p65 complex formations were demonstrated by in vivo FRET analysis, and EGR-4
and NAB-2 binding is shown in pull-down assays. These results suggest that NAB-2
breaks up the interaction between EGR-4 and p65 by binding simultaneously to both
proteins in this complex.
EGR proteins bind not only to different transcription factors, but they bind to each
other and form heterodimers. EGR-EGR protein interaction has been shown in ‘pull-
down’ assays and confirmed by FRET experiments. Considering that these
heterodimers are not active in TNFa and ICAM-1 gene transcription, they most likely




1.1 The Immune System
The human immune system consists of several defense levels that prevent the
invasion of microorganisms. In lymphoid organs various immune cells are produced,
and these cells mature to play a central role in the defense from pathogenic
infections. The immune response of the host is divided into innate and adaptive
immune reactions. The innate immune response serves as a first line of defense and
is activated immediately after pathogens overcome mechanical and chemical barriers
of epithelial surfaces of the body. Innate immunity reacts immediately and does not
adapt or improve its effectiveness against previously encountered antigens. In
addition the innate immune response helps to activate an adaptive immune
response. This achievement relies to a great extent on the family of Toll like
receptors, which have a crucial role in early host defence against invading
pathogens. The Toll like receptor family (TLR) consists of at least 11 members, which
are widely expressed on leukocytes. All TLRs sense different components of
microorganisms and trigger a multitude of antimicrobial and inflammatory responses.
In addition, a subset of TLR-induced signals is dedicated to the control of adaptive
immunity (Iwasaki and Medzhitov, 2004, Takeda and Akira, 2005, Akira and Takeda,
2004). Dendritic cells are the key cell type that couples TLR-mediated innate immune
recognition to the initiation of T cell and B cell activation.
The adaptive immunity consists of millions of antigen specific lymphocytes. Due to its
specificity, the adaptive immunity is more sophisticated and its memory enables
immunization and provides long lasting protection against particular pathogens.
The cells of the immune system derive from the bone marrow where many of them
mature. The two main types of progenitor cells in the bone marrow are the lymphoid
progenitor (gives rise to B and T lymphocytes) and the myeloid progenitor which
gives rise to different leukocytes (white blood cells), erythrocytes (red blood cells)
and megakaryocytes that produce platelets. Leukocytes are grouped into three major
categories – granulocytes, monocytes and lymphocytes. Their main function is to
combat infection and in some cases phagocytose and digest debris. Due to their
differential staining patterns granulocytes are divided into three groups - neutrophils,
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eosinophils and basophils, all produced in high numbers during immune responses.
Neutrophils play a crucial role in phagocytosis of microorganisms which makes them
important components of innate immune response to bacterial infection. Eosinophils
predominantly fight parasitic infections, while basophils release histamine and have a
role in allergic inflammation. Monocytes circulate in the blood stream, and mature
into macrophages upon leaving circulation and reaching tissues. Together with
neutrophils they present the main phagocytic cells of the immune system. Monocytes
also give rise to dendritic cells that can ingest foreign organisms and are important to
present antigen.
The two main classes of lymphocytes are T and B cells, and these cells are
responsible for cellular or humoral immune responses. The T cells are responsible
for destroying infected or cancerous cells and for coordinating adaptive immune
response by secretion of a wide variety of cytokines. Every B cell posses an
immunoglobulin molecule on its surface (Ig), which recognizes a special, three-
dimensional epitope of the antigen. After encountering antigen, B cells differentiate
either in effector plasma cells that produce vast numbers of immunoglobulins, or
memory cells that persist in the body for a long time and develop into plasma cells
only after re-encounter with the same antigen.
In case of infection, antigen is taken up by dendritic cells that travel from the site of
infection to the lymph nodes via lymphatic vessels. Due to the morphology of lymph
nodes, dendritic cells present the antigen first to the T cells which become activated,
and in turn select and activate B cells. Both lymphocytes undergo proliferation and
differentiation and leave lymph nodes as effector cells. In this way adaptive immune
response is initiated in the regional lymph nodes and in the initial phase takes several
days to mature (Janeway, 2001).
1.2 Inflammation
Inflammation is a complex sequence of events occurring in host tissue upon
infection. It is the beneficial host response that acts to eliminate pathogens and
ultimately leads to restoration of tissue structure and function. Cardinal signs of
inflammation are heat, redness, swelling, pain and loss of function.
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The inflammatory response represents an example of integration and synergy of
innate and adaptive immune systems. Mediators of both systems work together in
attracting monocytes and neutrophils to the site of infection. Both cell types posses
surface receptors that recognize and bind bacterial surface proteins. Neutrophils are
the earliest cells to be recruited to the site of infections, followed by monocytes that
translocate from blood to infected tissues where they differentiate into macrophages.
Macrophages and neutrophils represent most important phagocytic cells responsible
for killing pathogens. Macrophages are also extremely active in releasing a variety of
toxic products (oxygen species that destroy invading organisms), cytokines and
chemokines that facilitate communication and interaction between immune cells.
These events mark the initiation of the inflammation process. The release of
vasoactive and chemotactic mediators leads to an increase of vascular diameter and
local blood flow which causes heat and redness. Following upregulation of
expression of adhesion molecules on endothelial cells facilitates adherence of
leukocytes to the endothelium and their migration to the inflamed area. Increase of
vascular permeability results in the loss of fluid and plasma proteins in the tissues
provoking swelling and pain. A complex collection of serum proteins termed
complement recognizes microbial surfaces but not host cells, and contributes to the
local inflammation by releasing small peptides that act in several different ways. The
newly generated C3a and C5a peptides increase vascular permeability, induce
expression of adhesion molecules, act as chemoattractants and activate phagocytes
and local mast cells in releasing histamine and TNFa (Fig. 1).
Fig. 1: Bacterial infection triggers an inflammatory response.
Bacteria trigger macrophages to release cytokines and chemokines that increase permeability of blood




The final steps in inflammatory processes include the formation of a physical barrier
that prevents the spread of infection, and reparation of injured tissue. Kinin and
coagulation systems are two enzymatic cascades of plasma proteins triggered by
tissue ie. blood vessels damage. The formation of the blood clot prevents pathogens
from entering the bloodstream and so limits the spread of infection. An uncontrolled
inflammatory response can lead to sepsis, that can lead to the failure of vital organs
and death.
The resolution of inflammation is a highly regulated process, comprising suppression
of pro-inflammatory gene expression, leukocyte migration and activation, followed by
inflammatory cell apoptosis, phagocytosis and clearance (Lawrence et al., 2002).
1.2.1 Mediators of inflammation
The process of inflammation is regulated by a complex cascade of various mediators.
These mediators coordinate and control an ordered sequence of events, resulting
eventually in clearance of infection. The various inflammatory mediators can be
divided in several classes: amines, lipid mediators, complement, cyclic nucleotides,
adhesion molecules, cytokines, chemokines and steroid hormones.
Vasoactive amines (histamine, bradykinin) and lipid mediators (prostaglandines and
leukotrienes) promote the increase in vascular permeability leading to the exit of fluid
and proteins from blood and their accumulation in the local tissue. In this way formed
edema causes pain and accumulation of plasma proteins (complement mediators)
that help attract antibody and phagocytic cells to the site of an infection. Increased
vascular permeability and fluid accumulation increase lymphatic drainage bringing
antigen presenting cells to the nearby lymph nodes.
Cytokines are small proteins released by a number of cells in response to various
stimuli, and they influence the behavior of immune cells by binding to specific
receptors. According to their structure cytokines can be divided into several families:
chemokines, interferons, family of hematopoietins and TNFa.
Chemokines are chemoattractant proteins released by many different types of cells in
response to bacterial or viral infections or agents that cause physical damage. They
act mostly on leukocytes like monocytes (MCP-1) and neutrophils (IL-8), recruiting
them to the site of infection.
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The hematopoietin family includes growth hormones and many interleukins that play
a role in both innate and adaptive immunity. Interleukins are produced by T cells,
mast cells, macrophages, epithelial and various other cells and act as T and B cell
activators and stimulators of growth and differentiation of the myeloid cell lineage.
Representatives of this large family are: IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL-11,
IL-13 as well as G-CSF and GM-CSF. IL-10 and IL-13 are known as anti-
inflammatory cytokines, inhibiting macrophage inflammatory cytokine production,
while IL-1 and TNFa are the best investigated proinflammatory cytokines, inducing
the endothelial cell expression of adhesion molecules which facilitate adhesion of
circulating neutrophils to the vascular endothelium. IL-1, IL-8 and IL-10 strictly
speaking cannot be classified as members of the hematopoietin family due to their
structural differences.
The TNF family includes TNFa and TNFß, LT-ß, CD40L, FasL, CD27L, CD30L and
Trail cytokines, all produced by T cells as well as macrophages, B and mast cells.
These proteins take part in innate and adaptive immune response and play an
important role in local inflammation, lymph node development, T and B cell
proliferation and apoptosis. Proteins of the TNF family are produced in membrane
bound and secreted form, and react with members of the TNF receptor family
(TNFR).
Interferons play a significant role during viral infections. They are found to interfere
with viral replication and so block spreading of viruses to uninfected cells. IFN-γ is
produced by T and NK cells, IFN-a and IFN- ß by leukocytes, fibroblasts and many
other cell types following the infection with viruses.
Cell adhesion molecules mediate the binding of blood leukocytes to the vascular
endothelial lining and promote their translocation to the inflamed tissues. Cell
adhesion molecules are divided into three groups : selectins, integrins and the
immunoglobulin superfamily. P- and E- selectins initiate the process of leukocyte-
endothelial interactions, which is subsequently strengthened by ICAM-integrin
binding. ICAM-1 and ICAM-2 as well as VCAM–1 are expressed on the inflamed
endothelium and bind tightly leukocyte expressed integrin proteins (LFA-1, Mac-1
etc.), so enabling leukocyte recruitment to the site of infection.
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1.2.2 The role of transcription factors in inflammation
Inflammatory processes are controlled and regulated by a variety of mediators that
function to recruit leukocytes to the site of inflammation and activate their gene
transcription machinery to induce of synthesis inflammatory mediators. Transcription
factors are central to this process. Stimulation of cells and signal transduction from
the cell surface to the nucleus results in upregulation of various transcription factors
that subsequently bind to promoter regions of many inflammatory genes and so
regulate their transcription.
Transcription is defined as the synthesis of RNA molecules using gene coding DNA
as a template. The DNA regulatory sequences that control gene transcription include
promoter, where the general transcription factors bind to, and enhancer region to
which gene regulatory proteins bind to. The RNA polymerase, general transcription
factors and various coactivators form a basal transcription complex that binds to the
DNA promoter sequence and mark the transcription start point. Gene regulatory
proteins bind sequence specifically to special consensus sequences in enhancer
region, and promote or inhibit the assembly of transcriptional complex at the start
point of transcription. As an example of promoter sequences, promoters of two









EGR NFκB NFκBSP-1 SP-1 NFAT
Fig. 2: Regulatory elements of TNFα and ICAM-1 promoters
Binding sites for various transcription factors in the promoter regions of the TNFα and ICAM-1 gene.
NF-κB and NFAT transcription factors are able to bind to the same consensus sequences.
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Transcription factors can bind as monomers, dimers or higher-ordered polymers and
exercise multiplicative effect on RNA synthesis by recruiting necessary proteins to
the reaction site. This phenomenon is termed transcriptional synergy and is observed
between different gene activators as well as between multiple molecules of the same
activator bound to the regulatory elements.
Transcription factors that are necessary for the expression of a large number of
inflammatory mediators include EGR, NF-κB, AP-1, NFAT and STATs (Handel and
Girgis, 2001, Manning and Rao, 1999). The stimuli that upregulate their transcription
and their target genes are presented in Table 1.
Table 1: List of important inflammatory mediators and transcription factors that are involved in
their transcriptional regulation.
Stimuli Transcription factors Regulated genes
NGF, PHA, PMA, calcium






CD23, Fas, bFGF, LH-β,
TF, PDGF-A, PDGF-B, p53,
EGR-1, EGR-4, HoxB2,
TGF-β1 etc.
TNFα, IL-1, UV, H202, LPS etc. NF-κB protein family
IL-1, IL-2, IL-6, IL-8, TNFα,
E selectin, VCAM-1, ICAM-
1, MIP-1, MCP-1, RANTES
etc.
TCR, BCR, histamine - and
thrombin receptors etc.
NFAT protein family
IL-1, IL-2, IL-4, IL-5, IL-8, IL-
13, TNFα, GM-SCF, IFNγ,
CD40L, FASL, ICAM-1 etc.
IFNs, CSF, IL-1through IL-15
etc.
STAT protein family IL-2, IFNγ, IL-4, Fos, E
Selectin, ICAM etc.
NGF,TNFα, IL-1, UV, H202,
LPS, stress, TCR etc. AP-I protein family




1.3 The ‘Immediate early’ genes
The immediate early genes are activated immediately upon cell stimulation, through
various signaling pathways. The immediate early genes regulate G0-G1 transition and
are defined by fast induction of transcription, without de novo protein synthesis. Level
of their transcripts decrease to baseline within a few hours after stimulation. The
immediate early family includes genes encoding transcription factors (ie. c-fos),
extracellular matrix molecules (ie. thrombospondin-1), cytoskeletal proteins (ie. ß-
actin), metabolic enzymes (ie. cyclooxygenase-2) and signaling molecules (ie. MKP-
1) (Miano and Berk, 1999). A subclass of ‘immediate early’ transcription factors are
early growth response proteins (EGR).
1.4 The ‘Early growth response’ protein family
The ‘early growth response’ proteins (EGR) are transcription factors EGR-1, EGR-2,
EGR-3 and EGR-4 classified in one family on the basis of their characteristic DNA
binding domain. The DNA binding domain of EGR proteins consists of three
conserved zinc finger motifs of the Cys2His2 type, that show the homology of over
90% within the family members. EGR proteins are expressed in various body cells
(epithelium, immune system, nervous system, muscle, cartilage, bones etc.) and
function to couple the early cytoplasmic events to long term changes in gene
expression.
Early growth response genes were isolated from different systems – human, mouse
and rat, by different groups and described with different names. EGR-1 was first
isolated from nerve growth factor (NGF) stimulated rat PC12 cells (NGFI-A;
Milbrandt, 1987). The mouse homologues of EGR-1 are: TIS8 (Lim et al., 1987, Lim
et al., 1989), Krox-24 (Lemaire et al., 1988) and zif268 (Christy et al., 1988). EGR-2
was isolated as a serum-stimulated gene from fibroblast cDNA library (Chavrier et al.,
1988b) and named Krox-20. The human homologue, EGR-2 was isolated from
activated T cells (pAT591; Zipfel et al., 1989) and from a fibroblast cells (Joseph et
al., 1988). EGR-3 was isolated from human serum stimulated 3T3 cells (Patwardhan
et al., 1991), from activated T cells (PILOT; Mages et al., 1991) and rats (Yamagata
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et al., 1994). EGR-4 was isolated independently by different laboratories (Milbrandt,
1987; Zipfel et al., 1989; Müller et al., 1991, Crosby et al., 1991).
1.4.1 The structure of EGR proteins
EGR transcription factors contain a DNA binding zinc finger domain in form of three
consecutive Cys2His2 motifs, their sequence is highly conserved within the members
of the family. Single EGR proteins also show similarity outside the DNA binding
region. Several short amino acid sequences appear to be related among the family
members, such as N terminal acidic regions or short basic sequences immediately
flanking the zinc-finger regions (Crosby et al., 1992, Lemaire et al., 1988, Lemaire et
al., 1990, Vesque and Charnay, 1992, Russo et al., 1993). N terminal domains of all
EGR proteins contain regions that consist predominantly of amino acids proline,





Fig. 3: Structure of EGR proteins
EGR proteins are characterized by highly conserved DNA binding zinc-finger domain, and divergent
flanking regions. All four proteins contain proline, serine, glycine and alanine rich sequences.
The zinc finger motif was first identified in the Xenopus laevis transcription factor
TFIIIA (Miller et al., 1985) and it represents one of most abundant DNA binding
domains in eukaryotes. Crystallographic studies of EGR-1 DNA binding domain show
that each zinc finger consists of an antiparallel β sheet and an α helix folded to form
a compact globular structure which is held together by a small hydrophobic core and
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by a zinc ion (Pavletich and Pabo,1991, Elrod-Erickson et al., 1996). The zinc is
coordinated by two conserved cysteins contributed by a β sheet and two histidines
from the α helix. All three zinc fingers wrap around the DNA, with α helices fitting into
the major groove (Parraga et al., 1988, Lee et al., 1989) (Fig. 4 A). Two arginine
residues in the first and third zinc finger and one arginine and one histidine residues
in the second zinc finger are responsible for binding to guanine nucleotides in the
DNA sequence GCG G/TGG GCG named EGR binding site or GC-rich binding site
(Fig. 4 B) (Christy and Nathans, 1989a, Crosby et al., 1991, Cao et al., 1993). EGR-1
is also shown to bind the G rich consensus sequence GGG GTG GGG named zinc-
finger protein binding site (ZIP) (Skerka et al., 1995, Skerka et al., 1997). This is an
overlapping binding motif for EGR-1 and another zinc finger protein Sp-1, hence ZIP
in the IL-2 promoter region.
A B
Fig. 4: The structure of zinc finger region of EGR proteins
(A) Each zinc finger forms an α helix that binds and fits into the DNA major groove (B) Contact of the
zinc finger domain of EGR-4 to its DNA consensus site. Each Cys2His2 zinc finger binds three
nucleotides. Contacts between amino acids of the zinc fingers and nucleotides of the DNA are
represented by arrows. Arginine and histidine residues form hydrogen bonds with guanine
nucleotides.
Distinct regions in EGR proteins have different functions such as DNA binding,
transcription activation or repression. N terminal regions of EGR-2, EGR-3 and EGR-
4 contain acidic amino acid sequences that constitute activation domains (Vesque et
al., 1992). In EGR-1 protein, serine and threonine rich N terminal domains have
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activation function. These domains might be phosphorylated to function as acidic
activators (Gashler et al., 1993).
The nuclear localization signal (NLS) of all EGR proteins is located in the zinc finger
DNA binding region, like in the zinc finger proteins Sp1 and TFIIIA (Gashler et al.,
1993). Both basic amino acids of the zinc finger DNA binding domain, and its three
dimensional structure play a role for protein translocation into the nucleus (Matheny
et al., 1994).
EGR proteins contain conserved amino acid sequences directly upstream zinc finger
domain that act as a binding site for the repressor proteins NAB-1 and NAB-2 (Russo
et al., 1995, Svaren et al., 1996). This region is referred to as repression domain
(R1).
1.4.2 Regulation of EGR protein expression
Expression of EGR proteins is regulated on different levels: transcriptional control (1),
RNA processing and transport (2), translation and protein activity (3), post
translational modifications (4), nuclear localization (5) and interaction with partner
proteins (6).
(1) The promoter regions of EGR genes contain several regulatory elements
which determine responsiveness on various stimuli in different cell types. Various
stimuli activate the cascade of second messengers and consequently influence the
transcription of EGR proteins. Putative regulatory elements in the 5’ promoter region
of EGR proteins are serum response elements (SRE, with inner core called CArG
box), Sp-1 as well as AP-1 and AP-2 similar binding motifs, c-AMP response
elements (CRE) and CCAAT regulatory elements (Rangnekar et al., 1990, Christy et
al., 1988, Janssen-Timmen et al., 1989, Chavrier et al., 1989, Cao et al., 1992).
Serum response elements are responsible for both serum and PMA responsiveness
(Rangnekar et al., 1989). Expression of EGR proteins in vitro is induced through
calcium ionophore A23187, dibutryl-cAMP, cytokines and basic calcium phosphate
crystals (Day et al., 1990, Müller et al., 1991, Vaccarino et al., 1993, Zeng et al.,
2003). EGR-2 and EGR-3 are induced by cyclosporin A sensitive calcineurin
phosphorylation (Shao et al., 1997, Miyazaki and Lemonnier, 1988). All four EGR
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proteins are induced upon stimulation with phytohemagglutinin (PHA) and phorbol
12-myristat 13- acetate (PMA) in Jurkat T cells (Skerka et al., 1997).
(2) The amount of EGR-1 expressed upon IL-1β, IL-1α, TNF-β and TNF-α
stimulation depends on the mitogenicity of the inducing agent (Cao et al., 1992).
Translation of EGR-1 may not depend only on transcriptional induction, but on RNA
processing as well. RNA processing in form of phosphorylation of cap binding protein
eIF-4E is shown to promote cellular protein synthesis by stimulating the initiation of
mRNA translation (Cao et al., 1992, Rychlik et al., 1990).
(3) A further level of complexity is generated by the possibility of differential
translation of EGR mRNA. Two variants of EGR-1 proteins were detected in NGF
stimulated PC12 cells, with molecular mass of 73 and 75 kDa (Waters et al., 1990).
Lemaire et al., (1990) also describe two species of EGR-1 proteins of 55 and 61 kDa,
that have different stabilities. The 61 kDa EGR form arises either through non-AUG
translation or through post-translational modifications. After PHA or calcium
ionophore stimulation of PC12 cells two forms of EGR-1 proteins were identified,
which showed mobilities of 84 and 54 kDa (Day et al., 1990). The 54 kDa protein
represents the cytoplasmic variant of the protein, while the 84 kDa form is located in
the nucleus. The nuclear form of the protein exists as a phosphorylated and a non-
phosphorylated form (Day et al., 1990). Two EGR-2 protein variants were detected in
nuclear extracts of the brain (55 and 79 kDa (Mack et al., 1992). Herdegen et al.,
(1993) report differential localization of these EGR-2 variants. 79 kDa form is
localized predominantly in the nucleus and the 55 kDa form stays in the cytoplasm.
Different variants of EGR-3 and EGR-4 are not reported so far.
(4) Several post-translational modifications have been observed for EGR proteins
like phosphorylation, N- and O- linked glycosylation and redox state control
(Milbrandt, 1987, Beckmann and Wilce, 1997). A consensus site for phosphorylation
is present in the EGR-1 protein sequence at the Thr/Ser-Gly-Arg site, nucleotide 688
(Milbrandt, 1987). Beside phosphorylation at serine residues (Lemaire et al., 1990),
other enzymes like C kinase, casein kinase II and tyrosine kinase also play a role in
phosphorylation (Lemaire et al., 1990, Russo et al., 1993). Phosphorylation
enhances the DNA binding activity of EGR proteins (Huang and Adamson, 1994).
Introduction
13
The functions of different types of glycosylation are not yet fully understood. The
cellular redox state may also control the DNA-binding activity of EGR proteins. The
DNA-binding activity is dependent on the presence of Zn2+, Fe2+ or Mn2+ ions (Cao et
al., 1990). Excluding Zn2+ ion from the protein renders such protein form inactive for
DNA binding (Huang and Adamson,1993).
(5) Nuclear translocation is another important mechanism that controls activity of
EGR transcription factors. The truncated form of EGR-1 lacking the zinc finger region
is detected only in the cytoplasm (Matheny et al., 1994, Vesque and Charnay, 1992).
The zinc finger region is highly conserved within the EGR protein family and is
important for nuclear translocation (Matheny et al., 1994, Crosby et al., 1992).
(6) The EGR proteins’ transcriptional activity is mediated through the interaction
with other transcription factors. Depending on the site of expression, EGR activities
are regulated by interaction with specific tissue factors. EGR-1 protein together with
homebox protein PTx-1 and the steroid factor 1 (SF-1) regulate expression of
luteinizing hormone LH-β (Lee et al., 1996, Tremblay and Drouin, 1999). EGR-1
physically interacts with CBP/p300 to modulate transcription of lipoxygenase (5-LO)
(Silverman et al., 1998). The EGR-1 protein and tumor suppressor p53 also form
physical complexes with in lung fibroblasts and in human lung cancer cells (Liu et al.,
2001, Nair et al., 1997). EGR-1 interacts with c-Jun in PC12 cells (Levkovitz and
Baraban, 2002) and EGR-1 binds directly to Sp-1 in bone marrow stromal cells
(Srivastava et al., 1998)  while interaction of EGR-2, EGR-3 and EGR-4 with Sp-1
has so far not been demonstrated. Interaction of EGR-1 and several viral proteins
like HBx, IE2, tax and tat was observed (Yoo et al., 1996a, Yoo et al., 1996b, Trejo et
al., 1997, Yang et al., 2002).
In the immune system, ICAM –1, IL-2 and TNFα cytokine transcription is regulated by
interaction of EGR proteins with proteins of the NFAT and NF-κB families (Decker et
al., 2003, Wieland et al., submitted). EGR proteins interact with p65 NF-κB unit in
regulation of the NF-κB-1 gene (Cogswell et al., 1997, Chapman and Perkins, 2000).
EGR-1, EGR-2 and EGR-3 proteins interact with repressor proteins of the NAB family
(Russo et al., 1995, Svaren et al., 1996).
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DNA binding sites of EGR interacting partners are either in close proximity of EGR
DNA binding sites or distant from them. Sp-1/EGR-1 overlapping binding sites are
present in several promoters such as TNFα, adenosin deaminase (ADA), tissue
factor (TF), macrophage colony stimulating factor (M-CSF), platelet derived growth
factor (PDGF-α), EGR-1 and in the IL-2 gene promoter (Krämer et al., 1994.,
Ackerman et al., 1991, Cui et al., 1996, Khachigian et al., 1996, Srivastava et al.,
1998, Cao et al., 1993, Skerka et al., 1995). In cases of ADA promoter and EGR-1
promoter itself, EGR and Sp1 protein binding is mutually exclusive, (Ackerman et al.,
1991, Cao et al., 1993), in contrast to TF-promoter in HeLa cells where both Sp-1
and EGR-1 are required for promoter’s maximal induction (Cui et al., 1996). EGR
proteins also interact with transcription factors whose consensus sequences are
located far up or downstream of the EGR binding sites, as for example in the ICAM-1
promoter (Wieland et al., submitted).
1.4.3 Function of EGR proteins
EGR proteins are regulators of transcription of various tissue specific genes. Studies
of animals that are deficient in individual EGR family members have provided clues
to the importance of single EGR proteins during development. Knock-out mice have
been generated and their phenotypes show that EGR proteins are involved in the
development of the reproductive system as well as the muscle and nervous systems
(Table 2).
Table 2: Phenotype of the EGR knock-out animals (O’Donovan et al., 1999)
Gene deleted Phenotype
EGR-1 Female infertility, marked reduction in pituitary LHβ
EGR-2 Defective peripheral nerve myelination, autonomous Schwann-cell
defect, abnormal hindbrain development, fusion of rhombomeres 3 and 5
EGR-3 Sensory ataxia, scoliosis, resting tremor, absence of muscle spindles
EGR-4 Male infertility, autonomous germ-cell defect
EGR proteins are expressed in various cells and tissues, which correlates with their
known role in differentiative and proliferative processes, as well as in apoptosis
(reviewed in Gashler and Sukhatme, 1995). The so far identified functional roles of
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EGR proteins in endothelial cells (1), the nervous system (2), tumorgenesis (3) and
the immune system (4) are following:
(1) In endothelial cells EGR-1 and EGR-2 expression is upregulated following
endothelial tissue injuries, together with the fibroblast growth factor (FGF-2)
(Khachigian and Collins, 1998, Svaren et al., 1998). In the nucleus EGR-1 protein
induces the expression of PDGF-α and PDGF-β and therefore plays a role in
pathogenesis of arteriosclerosis (Khachigian and Collins, 1989, McCaffrey et al.,
2000). EGR-3 plays a role as regulator of expression of genes required for spindle
morphogenesis (Tourtellotte et al., 2001).
(2) All four proteins of the EGR family are induced in the nervous system, either
through different neurotransmitters or through the nerve growth factor (NGF). They
play a major role in the development of the nervous system and in neuronal
excitation (reviewed in Beckmann and Wilce, 1997). EGR-2 protein controls the
expression of HoxB2 gene, a homeobox transcription factor required in hindbrain
segmentation (Sham et al., 1993). Protease nexin–1 (PN-1), widely expressed in the
nervous system and many non-neuronal tissues, is a target gene for EGR-1, and
possibly for other members of the EGR family.
EGR-1 proteins play a role in tumorgenesis, their activity depending strongly on the
cell context. Overexpression of the EGR-1 protein in cells of human fibrosarcoma
and other cancers suppresses cell growth due to transcriptional repression of the
apoptosis inhibitor Bcl-2 (Huang et al., 1995, Huang et al., 1998). Further on, EGR-1
is a positive regulator of the p53 tumor suppressor gene expression in mice embryo
fibroblast (Krones-Herzig et al., 2003). EGR-1 induces apoptosis in melanoma cells
(Nair et al., 1997, Liu et al., 1998) by upregulating transcription of p53 gene,
(followed by the synthesis of p53 mRNA and protein). EGR-1 interacts with c-Jun
transcription factor which is essential for neuronal apoptosis via transcriptional
activation of c-Jun target genes encoding pro-apoptotic proteins (Ham et al., 2000).
EGR-1 activates the expression of cdk inhibitor p21Cip1 and acts as tumor suppressor
(Ragione et al., 2003). Activation of EGR-1 synthesis by ultraviolet light was shown
directly to upregulate expression of the lipid phosphatase PTEN gene, leading to cell
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death (Virolle et al., 2001). In most of the cases EGR-1 does not function as ‘pro-
apoptotic’ protein per se, but requires cofactors to exhibit apoptotic activities.
Several reports show that EGR-1 proteins are constitutively expressed in the majority
of prostate tumors, and that they play a role in tumor development (Eid et al., 1988,
Thigpen et al., 1996). EGR-1 confers resistance to apoptotic stimuli (Hallahan et al.,
1995, Huang et al., 1998). Thus, pro-apoptotic activity of EGR-1 may depend on the
cell type and the nature of the cytotoxic stimulus.
(4) In the immune system EGR proteins play a significant role in cell development
and in transcriptional regulation of several immune genes. EGR-1 is important for the
differentiation of macrophages (Nguyen et al., 1993). EGR-1 is upregulated during
thymic selection and the development of immature CD4+8+ cells (double positive
cells) to mature T cells (Shao et al., 1997). The presence of EGR-1 is also crucial for
the proliferation of activated T lymphocytes (Perez-Castillo et al., 1993). In T cells
EGR proteins are shown to bind to promoter elements of various cytokines and
adhesion proteins and regulate their transcription - TNFα, IL-2, ICAM-1, FasL
(Krämer et al., 1994, Skerka et al., 1995, Decker et al., 2003, 1998, Dzialo–Hatton et
al., 2001). EGR-1 takes part in the transactivation of transcription factor nur 77, which
is important for the apoptosis of T cells (Williams and Lau, 1993, Woronicz et al.,
1994). EGR-1 also plays a role in the differentiation of pre-B cells (Dinkel et al.,
1989). Its synthesis is upregulated after B cell receptor stimulation and it regulates
transcription of the adhesion molecules CD44 and ICAM-1 that mediate interactions
between B and T cells (Maltzman et al., 1996a, Maltzman et al., 1996b). The
myeloblast cell lineage normally differentiates either to granulocytes or to
macrophages. EGR-1 and EGR-2 upregulation is observed during myeloblast
development into macrophages (Kharbanda et al., 1991).
Cell type specific transcription factors presumably influence the specific functional
activities of the individual EGR proteins. EGR-1 transactivates the platelet-derived α
chain gene in human embryonic kidney cells, but represses transcription of the same
gene in murine NIH 313 fibroblasts (Wang Z.Y. et al., 1992). In addition, the EGR-1
protein is demonstrated in negative regulation of the aminosin deaminase expression
(ADA) and its own expression (Ackerman et al., 1991). Similarly to EGR-1, EGR-4
also showed an autoinhibitory effect (Cao et al., 1993, Zipfel et al., 1997).
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1.5 The EGR-2 protein
The EGR-2 gene was simultaneously isolated from different organisms such as
human, mouse and rat, by different groups and described as gene controlling
proliferation and differentiation of eucaryotic cells. The human EGR-2 was isolated
from activated T cells (pAT591; Zipfel et al., 1989) and from fibroblast cells (Joseph
et al., 1988).The mouse homologue, EGR-2 was isolated as a serum-stimulated
gene from a fibroblast cDNA library (Chavrier et al., 1988b) and named Krox-20.
There is a 100% identity in the amino acid sequence of the zinc finger region
between human EGR-2 and mouse homologue Krox 20 proteins, and a 92% identity
between EGR- 2 and EGR-1 zinc finger regions. EGR-2 protein is rich in proline
(15%), serine (11%), alanine (8%), and threonine (7%) residues. EGR-2 is a
multidomain protein. Activational role is contributed to the two relatively acidic
transactivation domains (1-51 aa and 143-184 aa) (Vesque et al., 1992), while one
potent inhibitory domain (R1) interacts with repressor proteins NAB (Russo et al.,
1993, Svaren et al., 1996).
EGR-2 protein plays an important role in gene expression during development.
During mouse embryogenesis, the mouse homologue of EGR-2 is specifically
expressed in rhombomeres 3 and 5 of the developing hindbrain (Wilkinson et al.,
1989). This pattern of expression, which appears before morphological segmentation
and overlaps with that of several homeobox containing genes (Hox-2.7 and Hox 2.8),
raises the possibility that EGR-2 plays a role in the regulation of hindbrain
segmentation. The EGR-2 protein regulates several homeobox genes - Hoxa2,
Hoxb2 and Hoxb3 genes (Sham et al., 1993, Nonchev et al., 1996). Another target
gene of EGR-2 in brain development is EphA4 (transmembrane tyrosine kinase
receptor), which is involved in restricting the mixing of cells between odd and even
numbered rhombomeres (Mellitzer et al., 1999). EGR-2 also plays a major role in
inducing genes relevant for myelination, such as myelin protein zero (MPZ),
peripheral myelin protein (PMP22), myelin associated glycoprotein (MAG), myelin
basic protein (MBP) and Connexin 32 (Nagarajan et al., 2001). In EGR-2 null mice,
although myelination starts (Parkinson et al., 2003), myelin sheats do not form and
Schwann cells remain susceptible to cell death (Topilko et al., 1999).
In support of the role of EGR-2 in PNS myelination, several EGR-2 mutations have
been identified in patients with inherited myelinopathies – Charcot-Marie Tooth
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disease, Dejerine-Sottas syndrome and congenital hypomyelinating neuropathy.
Although most peripheral neuropathies are caused by mutations of myelin genes
MPZ, PMP22, MBP, MAG, and Connexin 32, mutations in the EGR-2 gene are also
involved in the pathogenesis of peripheral myelinopathies (Warner et al., 1998,
1999). Seven mutations are located within the zinc finger domain and affect binding
to DNA, while the eighth is located within the R1 domain. This mutation in R1 domain
abolishes interaction of EGR-1 with the NAB proteins, which results in increase of
transcriptional activity (Veneken et al., 2002).
In the immune system EGR-2 is expressed in the thymus, where cells are
undergoing antigen-driven selection (Chavrier et al., 1988) and is expressed
transiently in activated T cells (Skerka et al., 1997, Shao et al., 1997). EGR-2
expression is sufficient to induce Fas L transcription (Mittelstadt and Ashwell, 1999,
Dzialo-Hatton et al., 2001). EGR-2 is involved in the induction of myeloid leukemia
cell differentiation lineage and in the activation of human monocytes (Kharbanda et
al., 1991).
1.6 The NF-κB proteins
The family of nuclear factor κB (NF-κB) transcription factors consists of five members
- p50 (NF-κB1), p52 (NF-κB2), p65 (Rel A), c-Rel and Rel B. NF-κB was originally
described as a B cell nuclear factor that binds to an element in the kappa
immunoglobulin light-chain enhancer (Sen et al., 1986). NF-κB control of
immunoglobulin genes transcription implied the importance of these regulatory
proteins in the immune response and propelled the further research.
In situ staining of embryonic tissues shows that p50, p52 and p65 proteins are found
in virtually all cell types, with the highest expression in the thymus, while c-Rel and
Rel B are detected only in lymphoid tissues (Weih et al., 1994).
All five NF-κB proteins have Rel homology domain (RHD), an amino terminal region
of approximately 300 amino acids, which contains the nuclear localization signal
(NLS), and which is responsible for protein dimerization and DNA binding. NF-κB1
and NF-κB2 represent precursor forms additionally contain multiple copies of ankyrin
repeats at their carboxy termini. Ankyrin repeats mask the nuclear localization signal
in RHD, which results in containment of precursors in the cytoplasm, where they
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serve as reservoirs for the p50, p52 units and IκB-like ankyrin repeats (Baeuerle and
Henkel et al., 1994, Siebenlist et al., 1994). Splicing of the precursors produces p50
and p52 active forms, that translocate to the nucleus. In contrast, Rel B, c-Rel and
p65 do not require proteolytic processing to generate their active forms (Fig. 5). Rel B
















Fig. 5: The common structure of NF-κB proteins.
The Rel homology domain contains a nuclear localization signal and is responsible for DNA binding
and dimerization. Proteolytic processing of p105 and p100 proteins produces the active forms p50 and
p52 that lack ankyrin repeats and therefore can translocate to the nucleus. Proteins of Class II lack
ankyrin repeats that renders them constitutively active.
NF-κB proteins bind to the DNA as dimers and represent transcriptional active forms.
Next to the classical NF-κB heterodimer p50/p65, many other homo- and
heterodimers have been described, each exhibiting distinct properties. Different
dimers recognize slightly different DNA targets which explains the ability of NF-κB
proteins to differentially regulate gene expression.
In the cytoplasm NF-κB proteins are complexed to IκB inhibitors that mask NF-κB
nuclear localization signal. Activation of the NF-κB dimers depend on
phosphorylation-induced ubiquitination of the IκB proteins. Extracellular stimuli
including cytokines, growth factors, bacterial products, viral infections, physical and
oxidative stress etc. are shown to initiate a signaling cascade that leads to activation
of IκB kinases (IKK complex), that phosphorylate IκB proteins in complex with NF-κB
(DiDonato et al., 1997, Chen et al., 1996, Li, Z.W. et al., 1999, Ghosh et al., 2002).
Once IκB proteins are phosphorylated, poly-ubiquitinated and degraded, NF-κB
dimers are released and can translocate into the nucleus, where they induce the
activation of their target genes.
More then 150 NF-κB responsive genes have been identified, among them adhesion
molecules such as E-selectin, ICAM-1, VCAM-1 (Whitley et al., 1994, Lewis et al.,
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1994), various cytokines like TNF-α, IL-1α, IL-2, IL-6, IL-8 (Zie, Q.W. et al., 1994,
Chen C.C. et al., 1995) and enzymes COX-2 and iNOS that catalyze synthesis of
proinflammatory prostaglandins or nitric oxide (Pahl H.L., 1999). Because of its direct
role in transcriptional regulation of these cytokines, NF-κB plays a crucial role in
many inflammatory diseases – rheumatoid arthritis, asthma, inflammatory bowel
disease, sepsis, artherosclerosis etc. (Handel et al., 1996, Barnes and Karin, 1997,
Jobin and Sartor, 2000).
1.7 The NAB proteins
NAB proteins are transcriptional cofactors that are acting as modulators of EGR
protein activity. NAB-1 protein (NGFI-A-binding protein) was identified in a yeast two-
hybrid screen using the R1 inhibitory domain of EGR-1 protein (NGFI-A) as a bait.
NAB-1 proteins interact with EGR-1 proteins in vitro and repress EGR-1 mediated
activation in CV-1 cells (Russo et al., 1995). Following this discovery, another protein
was isolated that bears sequence similarity to NAB-1 and also represses
transactivation by EGR-1: NAB-2 (Svaren et al., 1996). While NAB-1 is ubiquitously
expressed in low levels, the level of NAB-2 is increased by some of the same stimuli
that rapidly induce EGR protein synthesis such as serum stimulation of fibroblast and
NGF stimulation of PC12 cells (Thiel et al., 2000, Svaren et al., 1996).
NAB proteins contain two conserved domains – NCD1 and NCD2 (Fig. 6). The NCD1
domain is sufficient for interaction with EGR proteins and mediates multimerization of
NAB proteins (Svaren et al., 1998). NCD2 mediates the NAB protein repressor








Fig. 6: NAB family members contain two conserved domains.
The NCD1 domain (NAB Conserved Domain) mediates binding to EGR and NAB multimerization,




Repressors are categorized as active and passive. Passive repressors mostly
interfere with protein-DNA binding, while active repressors are divided into quenching
repressors and those that work by direct mechanisms. Quenching repressors prevent
specific activators from transmitting their activating signal to the basic transcription
complex, while direct repressors repress transcription in a general term and are not
activator specific. NAB repressors act in general term and are not activator specific
(Swirnoff et al., 1998).
NAB proteins repress EGR mediated activation of a number of genes: tissue factor
(TF), PDGF-α, β, TGFβ1, VEGF (Houston et al., 2001), bFGF (Svaren et al., 1998)
and MMP-3 (Qu et al., 1998). However, NAB proteins can enhance EGR mediated
activation of the LHβ and FasL genes (Sevetson et al., 2000). NAB mediated
coactivation is dependent upon the NAB-EGR interactions and it maps to the NCD2
domain of the NAB protein. The number of promoter’s EGR binding sites ultimately
determine NAB function. In promoters with few EGR binding sites, the NCD2
mediated interaction could function to stabilize binding of the RNA polymerase
holoenzyme and so enhance transcription. In promoters with multiple, or high affinity
EGR binding sites, the NCD2 interaction might prevent transcriptional initiation by
trapping the holoenzyme in an overstabilized complex (Sevetson et al., 2000).
An additional model for dual function of NAB proteins was proposed by Thiel et al.,
2000. EGR proteins function solely as docking site for NAB proteins. Thus, low
concentrations of EGR proteins are probably neutralized immediately by NAB
proteins and EGR proteins function as transcriptional repressors (Barroso et al.,
1999, R.-P. Huang et al., 1998). When the concentration of EGR proteins increases
that of the NAB proteins, EGR proteins function as transcriptional activators.
Other proteins, including p53, WT1, retinoblastoma protein etc. show the same ability
to both activate and repress transcriptional activation. The p53 activator/repressor
functions are concentration dependent, activating at low protein levels and repressing
functions at higher levels (Kristjuhan et al., 1995)
NAB proteins may be located downstream from EGR-2 in a regulatory pathway. In
Krox 20-/- embryos, NAB genes are not expressed in the hindbrain, indicating that
these genes are downstream of Krox-20. Thus, Krox-20 controls the expression of its
own antagonists, and suggest that this feedback regulatory loop plays an important
role in the development of the hindbrain (Mechta-Grigoriou et al., 2000). EGR-2 is
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reported to induce NAB-2 expression and both proteins are co-regulated after nerve
injury in Schwann cells (Nagarajan et al., 2001). Induction of NAB-2 synthesis by
EGR-1 has also been shown, and is supposed to allow transient but not sustained




Early growth response genes (EGR) encode transcription factors that are transcribed
immediately upon stimulation of various cells, without de novo protein synthesis.
EGR proteins are expressed in cells of the immune system and regulate the
transcription of several inflammatory genes. Depending on interaction with other
transcription factors, EGR proteins activate or repress the expression of various pro-
inflammatory cytokines. Previous transfection assays showed EGR-1/p65 and EGR-
4/p65 complexes to be very potent activators of cytokine gene expression, while
EGR-1/p50 and EGR-4/p50 complexes rendered transcriptional inactivity. The
specific EGR inhibitor proteins NAB-1 and NAB-2 repress EGR mediated activity of
various genes such as TF, PDGF, VEGF, FGF. The function of NAB proteins in
inflammatory gene regulation is so far unknown.
The role of the EGR protein family member EGR-2 in inflammatory gene regulation is
largely undefined. Therefore it was the aim of the present study to investigate the
function of EGR-2 protein in immune reactions, and specifically to characterize the
role of EGR-2 in transcriptional regulation of TNFα and ICAM-1 inflammatory genes.
The following questions were asked:
- What is the cellular localization of the EGR-2 protein in unstimulated and stimulated
  immune cells and how does protein distribution reflects its function?
- Does EGR-2 protein form physical complexes with NF-κB immune regulators?
- How do EGR-2 and NF-κB regulate the transcription of TNFα and ICAM-1 genes?
- Do the transcriptional repressor NAB proteins influence the transcriptional activity
  of EGR-2 regulated inflammatory genes TNFα and ICAM-1?
- Are NAB proteins specific regulators of all EGR proteins?
- Are EGR proteins exclusive binding partners for NAB proteins?





2.1 Established cell lines and bacterial strains
HEK 293 cells Human embryonic kidney, ATCC number CRL-1573
Sf9 Insect cells Spodoptera frugiperda , Novagen 71104-3
Jurkat T cell line T cell leukemia, ATCC number TIB-152
Bacterial strain Escherichia coli, strain DH5α (Hannahan, 1983)
2.2 Cell culture reagents
Dulbecco's Phosphate Buffered Saline (BioWhittaker, Cambrex, Verviers, Belgium)
RPMI 1640 (Invitrogen, Karlsruhe)
Insect-Xpress medium (BioWhittaker, Cambrex, Verviers, Belgium)
Grace’s Insect medium (BioWhittaker, Cambrex, Verviers, Belgium)
Fetal Calf Serum (PAA Laboratories GmbH, Cölbe)
L-Glutamine (BioWhittaker, Cambrex, Verviers, Belgium)
Penicillin/Streptomycin (BioWhittaker, Cambrex, Verviers, Belgium)
Fungizone (BioWhittaker, Cambrex, Verviers, Belgium)
Bovine Serum Albumin (BSA) (Roth, Karlsruhe)
Phytohemagglutinin (PHA, Sigma-Aldrich GmbH, Dreisenhofen)
PMA (Phorbol 12-myristat 13-acetat, Sigma-Aldrich GmbH, Dreisenhofen)
2.3 Buffers and media
All the buffers were prepared with double distilled water and autoclaved at 121 °C
and 2 x 105 Pa for 20 min (ddH2O). Phosphate buffer saline (PBS – 3.3 mM NaH2PO4
x H2O, 6.7 mM Na2HPO4, 145 mM NaCl, pH 7.5) was prepared according to the
standard method (Sambrook et al., 1989) with minor changes. Phosphate buffer
saline with DTT and PMSF (PBS-DP), was prepared with PBS and 1 mM
dithiothreitol (Cleland’s Reagent, DTT, GibcoBRL) and 0.5 mM
phenylmethylsulfonylfluorid (PMSF, Roth, Karlsruhe) added shortly before use. Five-
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fold concentrated DNA loading buffer (0.25 % (w/v) Bromphenole, 0.25 % (w/v)
Xylencyanole FF, 30 % (v/v) glycerol in H2O), SDS - loading buffer (5x, 125 mM
Trisbase, 5 % SDS, 50 % (v/v) glycerin, 1 mg bromphenoleblue, 40 mg Orange G ad
100 ml ddH2O, pH 6.8) and SDS electrophoresis buffer (1 x, 25 mM Trisbase, 3.5
mM SDS, 0.16 M glycerin, ad 1l ddH2O) were all prepared according to Sambrook et
al, 1989.
Luria-Bertani (LB)-medium consists of Bacto 10 g trypton, 5 g of Bacto yeast extract,
10 g NaCl, ad 1 l H2O, pH 7.5. Luria-Bertani (LB) Agar was prepared from LB
medium supplemented with 20 g agar (DIFCO). For ampicillin selection 100 µg/ml of
ampicillin (Binotal, Grünenthal) was added.
2.4 Oligonucleotides
Table 3: PCR primers






Table 4: Eucaryotic expression plasmids for EGR proteins
Plasmid Structure Reference
pBSV-8His Size: 9755 bp, Marker: Ampr, Replikon: prok.
ori, Promoter: polyhedrin, codes for 8 x Histidin
Kühn and Zipfel, 1995
pBSV-EGR-1 Vector: pBSV-8His, Insert: human EGR-1-
cDNA, complete coding sequence, 8 x Histidin
Skerka et al., 1995
pBSV-EGR-2 Vector: pBSV-8His, Insert: human EGR-2-
cDNA, complete coding sequence, 8 x Histidin
this work
pBSV-EGR-3 Vector: pBSV-8His, Insert: human EGR-3-
cDNA, complete coding sequence, 8 x Histidin
Zipfel et al., 2003
pBSV-EGR-4 Vector: pBSV-8His, Insert: human EGR-4-
cDNA, complete coding sequence, 8 x Histidin
Zipfel et al., 2003
Materials and Methods
26
Table 5: Bacterial expression plasmids for NFκB and EGR proteins
Plasmid Structure Reference
pGEX-1 Size: 4,9 kb, Marker: Ampr, laclq, Replicon:





pGEX-p50 Vector: pGEX-1, Insert: human p50-cDNA,
complete coding region, GST
Serfling, Würzburg
pGEX-p65 Vector: pGEX-1, Insert: human p65-cDNA,
complete coding region, GST
Serfling, Würzburg








Table 6: Reporter plasmids for transient cell transfections
Plasmid Structure Reference
pGL-2 Size:5,6 kb, Marker: Ampr, Replicon: colE1, f1,
codes for the „Firefly“-Luciferase from Photinus
pyralis
Promega, Mannheim
pIC –5800 Vector:pXP-2,Insert:ICAM-1 promoter
fragment, coding region: +1/+5800
K.-O. Krönke,
Düsseldorf
pTNF-Luc Vector: pGL-2-Basic, Insert: TNF-α-promoter
fragment, coding region: -191/+34
Zipfel et al., 2003
Table 7: Expression plasmids for transient cell transfections
Plasmid Structure Reference
pSG5 Size: 3,7 kb, Marker: Ampr, Replicon: prok.,
euk. ori, Promoter: T7, SV 40 (early)
Stratagene, La Jolla,
USA
pSG5-EGR-1 Vector: pSG5, Insert: human EGR-1-cDNA,
complete coding region
Zipfel et al., 1997
pSG5-EGR-2 Vector: pSG5, Insert: human EGR-2-cDNA,
coding region: +1/1370
this work




pSG5-EGR-4 Vector: pSG5, Insert: human EGR-4-cDNA,
complete coding region +1/1461












pSG5-EGR-4-VI Vector: pSG5, Insert: human EGR-4-cDNA,
coding region 1/165, 1131/1392
Wieland et al.,
submitted
pSG5-EGR-4-VII Vector: pSG5, Insert: human EGR-4-cDNA,
coding region 168/339, 1131/1392
Wieland et al.,
submitted
pSG5-EGR-4-VIII Vector: pSG5, Insert: human EGR-4-cDNA,
coding region 342/510, 1131/1392
Wieland et al.,
submitted
pSG5-EGR-4-IX Vector: pSG5, Insert: human EGR-4-cDNA,
coding region 513/750, 1131/1392
Wieland et al.,
submitted
pSG5-EGR-4-X Vector: pSG5, Insert: human EGR-4-cDNA,
coding region 753/975, 1131/1392
Wieland et al.,
submitted
pSG5-EGR-4-XI Vector: pSG5, Insert: human EGR-4-cDNA,
coding region 513/975, 1131/1392
Wieland et al.,
submitted
pMTZT-p50 Vector: pMTZT, Insert: human p50-cDNA,
complete coding region
Siebenlist, Bethesda
pMTZT-p65 Vector: pMTZT, Insert: human p65-cDNA,
complete coding region
Siebenlist, Bethesda
pRL-SV40 Vector: pRL, Insert: renilla-luciferase-cDNA
(Rluc), cloned from Renilla reniformis
Promega, Mannheim
pJDM-Krox 20 Vector:pJDM 1118, Insert: mouse Krox-20-
cDNA, complete coding region
Milbrandt, St. Louis
Table 8: Fluorophore tagged expression plasmids
Plasmid Structure Reference
pECFP-C1 Size 4,7 kb, Marker: Kanr/Neor, Replicon:
prok., euk. ori. Promoter: SV40, pCMV
Clontech
pEYFP-C1 Size 4,7 kb, Marker: Kanr/Neor, Replicon:
prok., euk. ori. Promoter: SV40, pCMV
Clontech






pECFP-C1-EGR-2 Vector: pECFP-C1, Insert: human EGR-2,
complete coding region
Wieland, Jena
pEYFP-C1-EGR-2 Vector: pEYFP-C1, Insert: human EGR-2,
complete coding region
Wieland, Jena
pEYFP-C1-EGR-3 Vector: pEYFP-C1, Insert: human EGR-3,
complete coding region
Wieland, Jena

















Antibody Source Concentration Manufacturer
Anti-EGR-1-polyclonal rabbit 1: 400 Santa Cruz
Anti-EGR-2-polyclonal rabbit 1:400 Hiss Diagnostics
Anti-EGR-3-polyclonal rabbit 1:400 Santa Cruz
Anti-EGR-4-polyclonal rabbit 1:400 Skerka et al., 1997
Anti-NAB-2 goat 1:100 Santa Cruz
Anti-Flag mouse 1:500 Sigma
Anti-Protein C mouse 1:500 Roche
Anti-NF-κB p50, polyclonal goat 1:400 Santa Cruz
Anti-NF-κB p65, polyclonal goat 1:400 Santa Cruz
Anti-polyhistidine mouse 1:1000 Acris
Anti-mouse,HRP conjugated rabbit 1:400 Dako
Anti-rabbit, HRP conjugated swine 1:400 Dako
Anti-goat, HRP conjugated rabbit 1:400 Dako
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2.7 Other reagents and materials
If not shown separately, chemicals and reagents used in experiments were obtained
from following companies: Biomol (Hamburg), Merck (VWR International, Dresden),
Roth (Karsruhe), Eppendorf (Hamburg), Greiner (Frickenhausen), Qiagen (Hilden),
Nunc (Mannheim), Amersham Pharmacia Biotech (Freiburg), PALL Life Sciences
(Dreieich), Invitrogen (Karlsruhe), BD Biosciences (Heidelberg) and Sigma (Sigma-
Aldrich, Deisenhofen).
Reactions from 0.5 - 2 ml in volume were performed in Eppendorf reaction tubes.
Culture bottles, cell scrapers, pipettes and ’12 well plates‘ (3.5 cm2/well, NunclonTM
Multidishes) were ordered from Nunc (NuncTM Brand Products, Mannheim) and
Falcon tubes from Greiner (Frickenhausen).
Centrifugation took place in Eppendorf-Tablecentrifuge 5415D, Eppendorf-Cooling
centrifuge 5417R (Eppendorf, Hamburg) and Beckman AllegraTM 6KR Centrifuge
(Beckman Coulter, Unterschleißheim). Thermomixer comfort (Eppendorf, Hamburg),
magnet shaker IKA RCT basic (Merck, Dresden), Vortex Genie2 (Scientific
Industries, Merck, Dresden), roller mixer SRT1 (Stuart scientific, Merck, Dresden)
and the shaker Unimax 2010 (Heidolph, Merck, Dresden) were used. Photometrical
measurements of optical density of media and  DNA and proteins  concentrations
was performed in BioPhotometer (Eppendorf, Hamburg) and in UV7 visible




3.1 DNA and RNA techniques
In order to characterize different protein-protein interactions cDNA sequences of
relevant proteins were cloned in eucaryotic and bacterial expression vectors. Vectors
used in this work are presented in Tables 4-9.
3.1.1 RNA isolation and RT- PCR
mRNA was isolated from stimulated Jurkat T cells (1 µg/ml PHA, 20 ng/ml PMA for
2.5 h) using Straight A’s mRNA Isolation System (Novagen), according to the
manufacturer’s instructions. The concentration of RNA was determined as the
absorbance at 260 nm in spectrophotometer, the absorbance of 1 unit at 260 nm
corresponding to 40 µg of RNA per ml (A260 nm = 1 unit = 40 µg/ml). 10 µg mRNA
was reverse transcribed into cDNA using oligo (dT)20 primers, random hexamers and
1.5 µl Superscript II reverse transcriptase (SuperScript First-Strand Synthesis
System for RT-PCR, Invitrogen, San Diego, CA). 2 µl of cDNA was amplified in 50 µl
PCR reaction containing 100 pmol of the each specific primers, 10 µl of 1.25 mM
dNTP mix, 5 µl 10 x PCR Buffer and 1.5 µl Taq polymerase (Amersham Pharmacia
Biotech). For PCR reaction following conditions were used: an initial denaturation
step at 94 °C for 2 min, 40 cycles of 30 sec at 94 °C, 30 sec at 60 °C and 1.5 min at
72 °C, and final elongation step at 72 °C for 20 min. PCR products were separated
by gel electrophoresis and analyzed.
3.1.2 Polymerase chain reaction (PCR)
The primers presented in Table 3 were obtained from Invitrogen (Karlsruhe) in
lyophilized state, and diluted till desired concentration with ddH20. 100 µl of PCR mix
contained 10 x PCR-buffer (15 mM MgCl2, 0.5 M KCl, 0.1 M Tris pH 9.0) 200 µM
dNTP-Mix, 100 ng DNA template, 25 pmol 5´-Primer, 25 pmol 3´-Primer and 0.5 µl
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Taq-Polymerase (2.5 U; Amersham Pharmacia Biotech, Freiburg). Reaction was
performed in 200 µl PCR reaction tubes (Biozym Diagnostic, Hess. Oldendorf) using
Gene-Amp-PCR-System 9700 (Applied Biosystems, Darmstadt). The thermal cycler
conditions used for PCR reaction are shown below:
3 Step Cycling:
Denaturation 1 min 94 °C
Annealing 1 min 52 °C
Extension 1 min 72 °C
Number of Cycles 25 cycles
Final Extension 10 min 72 °C
PCR products, mixed with five-fold concentrated DNA loading buffer (0.25 % (w/v)
brominephenol, 0.25 % (w/v) xylenecyanol FF, 30 % (v/v) glycerol in H2O) (Sambrook
et al., 1989;), were separated by electrophoresis on 1.5 % agarose gel (Agarose NA,
Amersham Pharmacia Biotech, Freiburg) in 1 x TBE buffer containing 0.5 µg/ml
ethidium bromide. Electrophoresis was performed in horizontal chambers (wide mini-
sub Cell GT, Bio-Rad, Krefeld) using Electrophoresis Power Supply EPS 301,
Amersham Pharmacia Biotech, Freiburg. λ-DNA-Hind III and ΦX174 DNA-Hae III
(ready-to-use-Marker, Finnzymes, Finland) marker mixture was used to determine
the size of the products. The products were visualized using a UV illuminator
GeneGenius Bio Imagingsystem (Syngene, Merck, Dresden). The rest of the PCR
mixture was purified with „QIAquick PCR Purification Kit“ (Qiagen, Hilden), according
to manufacturer’s instructions. DNA was eluted by 30 µl ddH2O.
3.1.3 Restriction and ligation of DNA
DNA restriction was performed with restriction enzymes EcoRI, BglII and BamHI
(Amersham Pharmacia Biotech, Freiburg) and „One-Phor-All Plus“ buffer (10 x, 10
mM Tris-HCl, pH 7.5, 50 % glycerol, 100 mM KCl, 1 mM DTT, 0.1 mM EDTA, 300 µg
BSA/ml, Amersham Pharmacia Biotech, Freiburg). Restriction reactions were
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incubated in thermomixer for 2 h at 37 °C, after which the restriction was terminated.
The DNA was purified from restriction enzymes, and buffer and efficiency of
restriction was analyzed by gel electrophoresis. Digested DNA fragments and DNA
vectors were ligated using DNA ligase (Roche, Mannheim) and ligation buffer (10x
buffer: 660 mM Tris-HCl, 50 mM MgCl2, 10 mM DTT, 10 mM ATP, pH 7.5) in a total
volume of 12 µl, overnight at 12 °C in thermomixer. The relation vector - insert was
1:3 – 1:5. The results of ligation were analyzed by gel electrophoresis.
3.1.4 Preparation and transformation of competent bacteria
Transformation of competent bacterial cells was performed according to the standard
protocol (Dagert & Ehrlich, 1979). Escherichia coli, strain DH5α (Hannahan, 1983)
that contains following genotyp was used: sup E44, ?lacU169 (?80, lacZ?M15),
hsaR17, recA1, endA, gyr96, thi1 and relA1. For growing of the bacteria
corresponding volume of LB- or LB-Amp medium was infected with one bacterial
colony and the cells were grown overnight at 37 °C in shaking culture. After the
centrifugation (5 min, 3000 x g, 4 °C) pellet was carefully resuspended in 30 ml ice-
cold TFBI buffer (30 mM Na-acetate, pH 6.0, 50 mM MnCl2, 100 mM NaCl, 10 mM
CaCl2, 15 % glycerin), then kept on ice for 10 min and again centrifuged for 10 min at
4 °C and 3000 x g. The pellet was resuspended in 4 ml ice cold TFBII buffer (10 mM
MOPS, 75 mM CaCl2, 10 mM NaCl, 15 % glycerin) and aliquots of cells were stored
at –80 °C.
For transformation, 0.5µl of plasmid DNA was added to 100 µl of competent E. coli
cells, shortly mixed, incubated on ice for 30 min and treated for 45 s at 42 °C in
thermomixer (400 rpm). Then, 200 µl of LB medium was added and mixture was
incubated for 45 min at 37 °C in thermomixer (400 rpm). 50-100 µl of the reaction
was seeded on LB-Amp plates, and incubated overnight at 37 °C (Heraeus B6420,
Heraeus, Hanau). For transformation with ligation reactions, 6 µl of ligation reaction
and 100 µl of competent E. coli were used to proceed in the same way. The whole




Small scale plasmid isolation from 1.5 ml overnight culture of single transformed E.
coli DH5α colonies was performed using Qiagen‚ QIAprep Spin Miniprep Kit‘
according to the instructions of the manufacturer. Overnight grown cell culture was
centrifuged for 1 min at RT, 14 000 rpm and the cell pellet was resuspended in 150 µl
of Solution I (100 mM Tris pH 7.5, 10 mM EDTA, 400 µg/ml RNase I). Subsequently,
150 µl of Solution II (1 M NaOH, 5.3 % SDS ad 26 ml ddH2O) was added and kept for
5 min at RT before adding 300 µl of Solution III (buffer with acetate and chaotrop).
After 5 min centrifugation at 14 000 rpm plasmid DNA was incubated on the column
for 1 min, centrifuged for 30 s at 14 000 rpm at RT and washed with 400 µl wash
buffer (Tris-EDTA in 48 ml absolute ethanol). Plasmids were eluted by centrifugation
at 14 000 rpm, RT for 1 min, with 50 µl of ddH2O.
Plasmid DNA used for transient transfections was prepared using ‚Plasmid Megakit‘
(Qiagen, Hilden). After growing transformed E. coli DH5α in 2 ml LB-Amp medium
overnight at 37 °C in shaking incubator, 500 µl of the culture was grown in 500 ml of
LB-Amp medium, at the same conditions. Cells were pelleted by centrifugation (15
min, 4 °C, 6000 rpm, Sorvall super T21) and the pellet was resuspended in 50 ml ice
cold Solution P1 (50 mM Tris-HCl, pH 8.0, 10 mM EDTA, 100 g/ml RNase A). After
centrifugation at 11 000 rpm at 4 °C for 30 min, 50 ml of Solution P2 (200 mM NaOH,
1 % SDS) was used to lyse the cells (RT, 5 min). 50 ml of Solution P3 (3 mM
potassium acetate, pH 5.5) was used to neutralize the reaction, and the reaction was
kept on ice for 30 min. Prior to loading, the column was equilibrated with 35 ml of
Solution QBT (750 mM NaCl, 50 mM MOPS (3-(N-morpholino)-propanesulfon acid),
pH 7.0, 15 % isopropanol, 0.15 % Triton X-100) and the lysate was filtered (filter
paper 5 x 5.8-fold). The column was washed with 200 ml of the Solution QC (1 mM
NaCl, 50 mM MOPS, pH 7.0, 15 % isopropanol) and eluted with 35 ml of the QF
Solution (1.25 M NaCl, 50 mM Tris-HCl, pH 8.5, 15 % isopropanol). DNA was then
precipitated with 0.7 volumes of isopropanol, centrifuged (30 min, RT, 3500 rpm),
washed with 5 ml 70 % ethanol and then washed again in 1 ml of 70 % ethanol in 1.5
ml Eppendorf tube. The pellet was dried and DNA was dissolved in ddH2O. After




Sequencing was preformed according to ‚Cycle-Sequencing‘ method from Sanger
(1977) using ‚BigDye Terminator v3.1 Cycle Sequencing Kit‘ in ABI-Prism 3100
(Genetic Analyser, Applied Biosystems, Darmstadt).
Sequencing of the DNA sequences in pSG5 vector was performed using following
primers: pSG5 forward (ctcctgggcaacgtgctggtta) and pSG5 reverse
(ggacaaaggagaagtagaatgc). For the sequencing of pBSV-8-His expression vectors,
pBSV-8His forward (5’-tttactgttttcgtaacagttt) and pBSV-8His reverse (5’-
ttccatccaacgacaagcttca) were used. Obtained sequences were compared with the
data base using the ‘standard nucleotide Blast’ program.
3.2 Cell culture methods
3.2.1 Cultivating of mammalian and insect cells
Cell culture work with Sf9 insect cells, HEK 293 and Jurkat T cells was preformed
under sterile conditions at the sterile tissue culture hood HeraCell (Heraeus, Hanau).
For all microscopic analysis Axiovert 25 inverse microscope (Carl Zeiss, Jena) was
used.
HEK 293 cells were cultivated in 20 ml RPMI 1640 medium supplemented with 10 %
of heat-inactivated FCS and 1 % w/v L-glutamine (200 mM). Cells were cultivated in
80 cm2 culture flasks at 37 °C and 5 % CO2. Change of the medium and passaging of
the cells took place three times a week. Cells were scraped from the bottom of the
flask at a confluence of 70 %, centrifuged (5 min, 1200 rpm) and split in ratio 1:10 –
1:20 in a fresh culture medium. Jurkat T cells were cultured in suspension, in RPMI
medium, under the same conditions.
Insect cell line Sf9 (Spodoptera frugiperda) was cultured in 35 ml Insect-Xpress-
Medium supplemented with 4 % heat-inactivated FCS, 100 U/ml penicillin, 100 µg/ml
streptomycin and 0.1 % fungizone. Cells were grown in monolayers in 185 cm2 cell
culture flasks in the incubator at 27 °C and 95 % humidity. Medium was changed
three times a week in a way that cells were scraped and centrifuged (5 min, RT, 1200
rpm). The cells were then split in ratio 1:3 or 1:4 in 15 ml of Grace’s Insect medium
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and left to adhere for 20 min at 27 °C in the incubator. Adhering medium was
consequently changed with culture medium.
3.2.2 Transient transfections and Luciferase reporter gene assay
Transient transfection of human HEK 293 cells (human embryonal kidney cell line)
was performed in ’12 well plates‘ at 50-70 % confluence using FuGENE TM 6 (Roche,
Mannheim). Plasmids used for transfections are presented in Tables 6 and 7.
Transient transfections were performed according to the recommendations of the
manufacturer (Roche, Mannheim). For each transfection 4 x 105  cells were seeded
and transfected with 0.2 µg reporter plasmid, 0.6 µg of expression plasmids and
0.032 µg of pRL-SV40. The concentration of DNA was kept constant by addition of
pSG5-plasmid DNA. After transfection cells were incubated for 18 hours, at 37 °C.
After that time cells were harvested, washed two times with 1 x PBS and lysed with
400 µl of ‚Passiv Lysis Buffer‘ (Promega). Luciferase activity was measured with the
„Dual-Luciferase TM“-Reporter assay system. 5 µl of cell lysate was mixed with 25 µl
of ‚Luciferase Assay Reagent II‘ (Promega) in microtiter plates (EG&G, Berthold).
Light emission of the firefly luciferase was measured for 10 s at RT in luminometer
LuMistar l; BMG, Labtechologies. By adding 25 µl of Stop & Glo TM  Reagent‘
(Promega) the activity of firefly luciferase was inhibited, and Renilla luciferase was
activated. Resulting light emission was again measured for 10 s. Each probe was
measured three times.
3.3 Baculovirus expression system
3.3.1 Generating recombinant Baculoviruses by co-transfection
Recombinant EGR-2 protein was expressed in the Baculovirus expression system. In
order to create the expression vector, the complete coding sequence of human EGR-
2-cDNA was inserted in the 9755 bp long vector pBSV-8His (Kühn and Zipfel, 1995).
Co-transfection of linearized baculovirus DNA and expression vector (pBSVHis EGR-
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2) with viral polyhedrin sequences flanking the EGR-2 insert allowed homologous
recombination to take place.
2 µg of pBSV-EGR-2 vector and 0.25 µg linearized „BaculoGoldTM-Baculovirus“ DNA
(PharMingen, BD) were incubated for 5 min at RT. In the next step, 500 µl of Hepes
buffer (25 mM Hepes, 140 mM NaCl, 125 mM CaCl2, pH 7.1) was added to the DNA
mixture and transferred to the cells. After 5 h of incubation at 27 °C, the buffer was
aspirated and culture medium (Grace’s medium supplemented with 10 % FCS) was
added. Five days post infection cells were checked for signs of infection. Supernatant
containing recombinant viruses was collected, and single recombinant viruses
obtained by plaque assay were used for virus amplification.
3.3.2 Plaque assay and virus amplification
Plaque assay was used to plaque purify virus and determine viral titer. 2 x 106  Sf9
insect cells were seeded on a 100 mm plate. Cells were allowed to attach for 30 min,
and medium was carefully replaced with Grace’s plain medium supplemented with 10
% FCS (‚Grace‘s culture medium‘). Cells were incubated overnight, at 37 °C. The
recombinant EGR-2 producing virus (in dilutions 10-3-10-8) was added to the cells.
Cells were incubated for 1 h on the horizontal shaker, which allowed viral infection of
the insect cells. In the meanwhile, sterile agarose solution was prepared, using low
melting point agarose (Agarplaque-Plus TM agarose) and mixed with Grace’s culture
medium until the concentration of 0.1 % was reached. The mixture was cooled in a
water bath to 37 °C, before adding to the cells. Cells were overlayed with the agarose
mixture. After 3-5 days, neutral-red agarose mixture was added on top for easier
visualization of plaques. After 3-5 days plates were illuminated with a light source to
identify single viral plaques, and individual plaques were picked in 500 µl of culture
Grace’s medium. Each plaque was used to infect a new culture in a plate (100 mm),
seeded with 2 x 105 cells, for 5 days. The virus containing supernatant was used for
further amplification steps. Amplification was repeated three times always using a
higher number of cells for infection, to attain a high viral titer (2 x 108 pfu/ml).
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3.4 Expression of proteins in eucaryotic and procaryotic systems
3.4.1 Expression of endogenous proteins
Jurkat T cells were cultivated in 300 ml RPMI 1640 medium supplemented with 10 %
heat-inactivated FCS and 1 % w/v L-glutamine (200 mM) in 185 cm2  culture flasks,
at 37 °C and 5 % CO2 (Heraeus, Hanau). After determination of the cell number, cells
were centrifuged (5 min, RT, 1200 rpm) and split in new culture flasks so that the
density was between 0.5 x 105  cells pro ml and 1 x 106 cells/ml. For obtaining EGR
proteins, cells (at the density of 1 x 106) were stimulated for 3 hours at 37 °C with 1
µg/ml PHA (Phytohemagglutinin) and 20 ng/ml PMA (Phorbol-12-myristat-13-acetat).
Endogenous NF-κB proteins were identified in the extract from Jurkat T cells
stimulated under the same conditions.
3.4.2 Expression of recombinant EGR proteins
For expression of recombinant proteins and production of viral stock solutions Sf9
cells (at the confluence of 60-70 %) were infected with EGR expressing recombinant
viruses using the multiplicity of infection (MOI) of 5-7. The plasmids used for
production of recombinant viruses are listed in Table 4. For the expression of the
recombinant protein cells were incubated for 3 days, and for the viral stock
production for a maximum of 10 days at 27 °C.
3.4.3 Extraction of proteins expressed in eucaryotic cells
Jurkat T cells grown at a density of 1 x 106 were harvested after three hours of
stimulation (1 µg/ml PHA, 20 ng/ml PMA), while Sf9 cells were harvested and
centrifuged three days post infection. Cell pellets were washed with 50 ml of cold
PBS and subsequently incubated in 1.5 ml of ice-cold hypotonic RSB buffer (10 mM
Tris-HCl pH 7.4, 10 mM NaCl, 1.5 mM MgCl2; added shortly before use: 0.5 mM
DTT, 0.1 mM PMSF) for 10 min on ice. The fraction obtained after centrifugation (30
s, 14 000 rpm, 4 °C) is cytoplasmic lysate. Pelleted cells were resuspended with one
bed-volume of ice-cold buffer C (20 mM HEPES pH 7.9, 420 mM NaCl, 0.2 mM
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EDTA, 25 % glycerin, 1.5 mM MgCl2; added shortly before use: 0.5 mM DTT, 0.1 mM
PMSF) and left on ice for 45 min with occasional vortexing. The lysate was
centrifuged (30 min, 14 000 rpm, 4 °C) and nuclear extract aliquoted and stored at –
80 °C. Proteins were analyzed by SDS-PAGE and Western blot, using specific
antibodies.
3.4.4 Affinity chromatography purification of recombinant EGR proteins
Recombinant EGR-proteins were expressed in Sf9 cells as histidine-fusion proteins
and were purified by Nickel - affinity chromatography. One milliliter of Nickel-NTA-
Agarose was incubated for 30 min in ‚charging‘ buffer (400 mM NiSO4), centrifuged
(10 min, RT, 2600 rpm) and equilibrated with 1.5 ml of binding buffer (5 mM imidazol,
120 mM NaCl, 3.3 mM NaH2PO4 x H2O, 6.7 mM Na2HPO4 x 2H2O, pH 7.5) for 5 min,
RT. After centrifugation cell extract was added to the column and incubated overnight
at 4 °C. After extensive washing proteins were eluted from the column in 2-3 steps,
each time with 200 µl of elution buffer (500 mM imidazol, 120 mM NaCl, 3.3 mM
NaH2PO4 x H2O, 6.7 mM Na2HPO4 x 2H2O, pH 7.5) for 1 h, at 4 °C. All the fractions
were separated by SDS-PAGE and analyzed by Western blotting, using specific
antibodies. Protein aliquots were kept at –80 °C. Additionally, protein concentration
was measured in the Biophotometer (Eppendorf, Hamburg).
3.4.5 Expression and extraction of E. coli expressed recombinant proteins
Protein expression in E. coli was performed following the standard method (Smith
and Johnsen, 1988), with few alterations. Vectors used for expression of proteins are
listed in Table 5. Recombinant NF-κB proteins were expressed in E. coli DH5 α cells.
An overnight culture of transformed cells was grown in 100-200 ml of LB medium (0.2
% glucose, 50 µg/ml ampicillin) at 37 °C until the OD600 0.6 – 0.8. Protein expression
was induced by adding 0.4 mM IPTG (isopropyl-1-thio-β-D-galactosid; Stratagene, La
Jolla, USA) for 1-2 h, at 37 °C. The cells were centrifuged for 15 min, 2800 x g, at 4
°C and washed with 50 ml ice-cold PBS-DP. Thereafter, cells were resuspended in 2-
4 ml ice-cold Dulbecco‘s PBS-DP and sonicated (1 min, level 10 of Sonifier II,
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Branson, Dietzenbach). Alternatively, Protein C tagged proteins were resuspended in
TBS-Ca buffer (20 mM Trisbase, 150 mM NaCl, 1 mM CaCl2). The lysate was
centrifuged, for 10 min at 10 000 x g, at 4 °C and was separated by SDS-PAGE and
analyzed by Western blot analysis. Lysates were kept as single-use aliquots at – 80
°C or used directly for protein purification on a ‚GST‘ column.
3.4.6 Affinity chromatography purification of E. coli expressed proteins
Bacterially expressed, glutathione-S-transferase (GST) tagged NF-κB fusion proteins
were purified by binding of the 26 kDa glutathione-S-transferase from Schistosoma
japonicum on its substrate glutathione. Glutathione agarose (Sigma-Aldrich,
Deisenhofen) was prepared and stored according to the instructions of the
manufacturer. 1 ml of glutathione agarose was washed three times with PBS-DP.
After centrifugation (5 min, 4 °C, 500 x g), 1 ml of cell extract was added to the
column and incubated overnight at 4 °C. The column was washed three times with 10
column volumes and once with one column volume of PBS-DP. Elution was
performed three times, each time with 200 µl elute buffer (10 mM glutathion
(reduced, Roche/Boehringer, Mannheim) in 50 mM Tris, pH 8.0).
All purification fractions were tested by Western blot analysis and kept in aliquots at –
80 °C.
3.5 Confocal Laser-Scanning Microscopy and Fluorescence
Resonance Energy Transfer (FRET)
For Laser Scanning Microscopy and FRET analysis, Jurkat T cells (2 x 107) were
cotransfected with EYFP and ECFP plasmids (Table 8) (1 µg DNA each)
respectively, using FuGene 6 (Roche). After incubation overnight at 37 °C cells were
harvested, fixed in 3.8 % paraformaldehyde for 15 min and subsequently mounted on
microscope slides using antifading mounting medium „Vectashield“ (Vector
Laboratories, Burlingame, CA, USA) with preadded DAPI for cellular DNA staining.
The microscope was a Zeiss-LSM-510 META laser scanning confocal microscope
(Carl Zeiss, Jena, Germany) equipped with the META addition to acquire both,
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stacks in z-axis and lambda-stacks (light wavelengths) based on an Axiovert 200 M
stative. The microscope was normally operating with a 40 mW argon laser (Lasos,
Göttingen, Germany), tuned to laser lines at 458, 488 and 514 nm. The Jurkat T cells
were examined with a “63 x/1.4 Zeiss Plan-Apochromat NA” oil immersion objective
(Carl Zeiss, Jena, Germany) and 2-fold zoom factor. CFP fluorescence was excited
at 458 nm and signals were detected with the META detector set for 490 to 520 nm.
YFP fluorescence was achieved at an excitation of 514 nm and detected at 559 to
615 nm. For the acquisition of FRET signals CFP was excited with a laser set to 458
nm. FRET signals were detected in the YFP-channel of the META detector set to 559
to 615 nm. Interaction of the proteins was further confirmed by acceptor
photobleaching (Kenworthy, 2001). According to this procedure, if FRET is occurring,
then photobleaching of the acceptor (YFP) should yield a significant increase in
donor fluorescence (CFP). Cells were treated with a laser set to YFP setting by
scanning a region of interest (ROI) 100 times using a laser set to 514 nm and used at
100 % intensity. Before and after treatment, CFP images were collected to monitor
for changes in donor fluorescence. In order to minimize the effect of photobleaching
due to imaging, images were collected at 5 % of the laser intensity, more than 20
times less than the bleach intensity applied before. Each image was collected first for
FRET, followed by CFP, and at last for YFP fluorescence. In all measurements the
background (pixel values outside the cells) was very low (< 5 % of the signal).
3.6 Protein chemical methods
3.6.1 SDS-PAGE (Sodiumdodecylsulfate-polyacrylamid gel electrophoresis)
SDS polyacrylamide gel electrophoresis was carried out with - Minigel apparatus
(Biometra, Göttingen), according to standard method (Laemmli et al., 1970).
Concentration of separating gels were chosen according to the size of the proteins,
between 10 % and 15 %. Separating gel contained separating buffer (0.35 M Tris,
0.4 % (w/v) SDS in 0.5 l H2O, pH 8.8) whose volume depended on concentration of
the gel, 25 µl 10 % APS (ammonium persulfate, Merck, Dresden), 5 µl TEMED
(Sigma-Aldrich, Deisenhofen) at concentration of 30 % acrylamid (Acrylamide/Bis
Solution (37.5:1); Invitrogen, Karlsruhe). 5.5 ml of the separating gel mixture was
Materials and Methods
41
poured between gel plates (10.5 cm x 9.8 cm, 1 mm spacer) and was polymerized in
presence of isobutanol. After 30 minutes isobutanol was removed with water, 2 ml of
stacking gel mixture (325 µl 30 % acrylamid, 625 µl stacking gel puffer (50mM Tris,
0.4 % SDS (w/v) in 0.1 l H2O, pH 6.8), 1.5 ml H2O, 12.5 µl 10 % APS and 2.5 µl
TEMED, was poured, silicon combs inserted and gel left to polymerize. Protein
probes were loaded onto the gel with SDS - loading buffer (5x, 125 mM Trisbase, 5
% SDS, 50 % (v/v) glycerin, 1 mg brominephenolblue, 40 mg orange G ad 100 ml
ddH2O, pH 6.8) (Sambrook et al., 1989). Electrophoresis was performed in vertical
chambers at 10 mA (Consort E844 and E865, Merck, Dresden) pro gel through
stacking and 15-20 mA through separation gel. 1 x SDS electrophoresis buffer (25
mM Trisbase, 3.5 mM SDS, 0.16 M glycerin, ad 1l ddH2O) (Sambrook et al., 1989)
served as running buffer while 5 µl prestained protein ladder (Fermentas) was used
as a molecular weight marker.
3.6.2 Silver staining
Proteins were visualized by silver staining. Silver staining was performed by standard
method (Shevchenko et al., 1996) with some modifications. After electrophoresis gels
were fixed in solution 1 (30 % (v/v) ethanol, 30 % (v/v) acetic acid), rinsed for 10
minutes in solution 2 (20 % (v/v) ethanol) and washed with water for 10 min. After
sensitation for one minute in solution 3 (1.26 mM sodium thiosulfate) gels were
incubated in solution 4 (10 mM silver nitrate) for 30 minutes. Gels were then shortly
washed in water and developed in solution 5 (37 % formaldehyde (0.7 ml/l),
potassium carbonate 0.37 M sodium thiosulfate (6.3 µM). The reaction was stopped
using solution 6 (0.4 M Tris base, 2.5 % acetic acid) for 1 min. At the end, silver
stained gels were incubated in 30 ml solution (5 % (v/v) glycerin, 10 % (v/v) ethanol)
and dried with ‚DryEase Mini-Gel Drying System’, Invitrogen (Karlsruhe).
3.6.3 Protein transfer and Western blot
After electrophoresis, proteins were transferred onto nitrocellulose membrane (6.5 x
9 cm, ProtranBA, Schleicher & Schüll) using semi-dry transfer method, in ‚Semi-Dry
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Blot chamber‘ with graphite electrodes (Keutz, Reiskirchen). In semi-dry blotting gel,
membrane and filter papers (Whatmann 3MM, Merck, Dresden) were assembled on
transfer apparatus in following order, from anode (+) to cathode (-): 6 pieces of paper
incubated in anode solution I (300 mM Tris, 20 % methanol, pH 10.4), 3 pieces of
paper and membrane pre-wetted in anode solution II (25 mM Tris, 20 % methanol,
pH 10.4) and gel and 9 pieces of paper incubated in cathode buffer (40 mM
aminohexane acid, 20 % methanol, pH 7.6). Air bubbles were carefully removed and
transfer was carried out at 0.8 mA/cm2 for 1-1.5 h (Consort E844 and Consort E865,
Merck, Dresden). After blotting, unspecific binding to the nitrocellulose membrane
was blocked through incubation in 5 % nonfat dry milk in 1 x PBS. Blots were probed
with the appropriate primary and secondary antibodies (Table 9) in 2.5 % nonfat dry
milk/PBS solution overnight at 4 °C or for 1 h, RT respectively, and detection was
carried out using ECL chemoluminescence reagent (Amersham, Freiburg) and
exposure onto Medical X-ray film (Fuji Photo Film, Düsseldorf).
3.6.4 In vitro protein binding studies
For the in vitro protein assays histidine tagged EGR proteins were immobilized on the
matrix and incubated with extracts prepared from stimulated Jurkat cells or with GST
tagged NF-κB recombinant proteins.
For the Nickel pull-down assay, cell extract from Sf9 cells infected with various EGR-
viruses was incubated with 400 µl Ni2+- NTA agarose (Qiagen, Hilden) overnight at 4
°C. The agarose matrix was centrifuged (5 min, 500 x g, 4 °C) and the supernatant is
named flow through. The matrix was washed four times with ice-cold 1 x binding
buffer (5 mM imidazol, 120 mM NaCl, 3.3 mM NaH2PO4 x H2O, 6.7 mM Na2HPO4 x
2H2O, pH 7.5) and in the next step either Jurkat cell extract or recombinant proteins
were added and incubated for 2-3 h at 4 °C. After extensive washing with binding
buffer the protein complexes were eluted with 1 x elute buffer (500 mM imidazol, 120
mM NaCl, 3.3 mM NaH2PO4 x H2O, 6.7 mM Na2HPO4 x 2H2O, pH 7.5). All the




40 µl of Anti-Flag Affinity Gel beads were washed twice in TBS buffer (50 mM Tris
HCl, 150 mM NaCl, pH 7.4) and centrifuged for 2 min at 10 000 rpm. HEK 293 cells
were lysed in 500 µl ice-cold lysis buffer (TBS, 0.5 % NP-40, Complete EDTA-free
protease inhibitor cocktail, Roche) and the clarified lysate was added to the
pretreated resin and incubated for two hours, at 4 °C on the rotating wheel. After the
incubation, the resin was washed four times with 500 µl of wash buffer, followed by
elution with 200 µl Flag peptide in TBS buffer (2x). Prior to performing SDS-PAGE,




4.1 Expression of native and recombinant EGR-2 and NF-κB
proteins
In order to investigate physical and functional interactions between EGR-2 and NF-
κB proteins, both native and recombinant EGR-2 and NF-κB proteins were
expressed. Recombinant EGR-2 was expressed using Baculovirus expression
system in Sf9 insect cells. Initially, mRNA was isolated from stimulated Jurkat T cells
and reverse transcribed in cDNA. EGR-2 cDNA was amplified using specific primers,
and PCR products were cloned into pBSV-8His expressing vectors (Kühn and Zipfel,
1995). EGR-2 pBSV-8His vectors were subsequently used for production of EGR-2
expressing recombinant viruses.
Recombinant proteins of NF-κB family were expressed in E. coli. All native proteins
were obtained from mitogen stimulated Jurkat T cells.
4.1.1 Expression of native and recombinant EGR-2 protein
Expression of the native EGR-2 protein was analyzed by SDS-PAGE and Western
blot analysis of nuclear extracts prepared from PHA/PMA stimulated Jurkat T cells.
The presence of the 55 kDa EGR-2 protein in stimulated cells is demonstrated (Fig. 7
A, lane 1) using specific EGR-2 antibody. The protein is not detected in extract
prepared from unstimulated cells separated under the identical conditions (Fig. 7 A,
lane 2).
Recombinant human EGR-2 protein was expressed in Sf9 insect cells. Nuclear cell
extract was separated by SDS-PAGE and analyzed by Western blotting using an
EGR-2 specific antibody. This approach identified recombinant EGR-2 as a protein
with an apparent molecular mass of 55 kDa (Fig. 7 B, lane 1), while it is not detected
in non-infected cells (Fig. 7 B, lane 2). In order to obtain mouse EGR-2 (Krox 20)
protein, HEK 293 cells were transiently transfected with vector containing full mouse
cDNA EGR-2 sequence. The presence of the 55 kDa mouse EGR-2 protein is
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demonstrated (Fig. 7 B, lane 3). EGR-2 protein is not detected in non-transfected
cells (Fig. 7 B, lane 4).
Recombinant human and mouse derived EGR-2 protein showed similar mobility as
the native, Jurkat derived EGR-2 protein.
Fig. 7: Expression of EGR-2 protein.
(A) Expression of native EGR-2 protein in Jurkat T cells. Nuclear extracts were prepared either from
stimulated (lane 1) or from untreated Jurkat T cells (lane 2). Extracts were separated by SDS-PAGE
and analyzed by Western blotting using specific EGR-2 antibody. EGR-2 protein is detected in extract
of stimulated Jurkat T cells (lane 1), but not in unstimulated Jurkat T cells (lane 2). Bands of higher
mobility most likely represent degradation products. (B) Expression of recombinant human EGR-2
protein in Sf9 cells (lane 1) and mouse EGR-2 in HEK 293 cells (lane 3). No specific bands are
detected in extracts prepared from non-infected Sf9 cells and untransfected HEK 293 cells (lanes 2
and 4).
4.1.2 Expression of native and recombinant NF-κB proteins
Expression of native NF-κB proteins p50, p65 and Rel B from stimulated Jurkat cells
was analyzed by Western blotting using specific antibodies. p50 was detected as 50
kDa protein, while p65 and Rel B have molecular weight of 65 and 69 kDa,
respectively (Fig. 8, lanes 2, 4 and 5). Recombinant NF-κB proteins were expressed
as Glutathione-S-Transferase (GST) -fusion proteins in E. coli (Fig. 8, lanes 1, 3).
After separation by SDS-PAGE and protein transfer to the nitrocellulose membrane,
recombinant NF-κB proteins were detected using specific antibodies. The


















































1 2 3 4 5
Fig. 8: Expression of native and recombinant NF-κB proteins.
Native p50, p65 and Rel B proteins were detected in extract prepared from PHA/PMA stimulated
Jurkat T cells (lanes 2, 4 and 5). Recombinant p50 and p65 were expressed as ‘GST’ fusion proteins
in E.coli (lanes 1 and 3). Faster migrating bands in lane 3 most likely represent degradation products.
4.2 Purification of recombinant EGR-2 and NF-κB proteins
The purification of the Sf9 expressed EGR-2 protein was performed using Ni2+-NTA
chelate chromatography (Fig. 9). Recombinant EGR-2 protein was bound to NTA
agarose, as is detected only in traces in flow through fraction (Fig. 9, lane 2). After
extensive washing (Fig. 9, lanes 3 and 4) protein was eluted (Fig. 9, lanes 5 and 6).
Detection of the EGR-2 protein in the cell extract and in the elute fractions presents
evidence of efficient protein purification.
The purification of E. coli expressed GST fusion NF-κB proteins was performed by
GST affinity chromatography. Recombinant p50 and p65 proteins were bound to
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Fig. 9: Purification of EGR-2 protein.
Recombinant EGR-2 protein was
coupled to the Ni-NTA matrix. Several
wash and elute fractions were obtained,
separated by SDS-PAGE and analyzed
by Western blotting using EGR-2
antibody. Purification is demonstrated as
the protein is detected in the elute (lanes
5 and 6) but not in flow through or wash
fractions (lanes 2, 3 and 4).
Results
47
lanes 3 and 4). Proteins were recovered in elute fractions (Fig. 10 A, 10 B, lanes 5
and 6).
Recombinant EGR-2 was purified using Ni2+-NTA chelate chromatography and NF-
κB proteins using GST affinity chromatography methods.
72 -
55 -























































Fig. 10: Purification of p50 and p65 NF-κB proteins.
(A) Purification of recombinant p50 protein.  The recombinant p50 protein was expressed in E. coli and
coupled to GST matrix. Several flow through and wash fractions were obtained, separated by SDS-
PAGE and analyzed by Western blotting using p50 antibody. Purification is demonstrated as the
protein is present in the elute (lanes 5 and 6) but not in flow through or wash fractions (lanes 2, 3 and
4). (B) Purification of recombinant p65 protein. GST matrix was incubated with the E. coli expressed
recombinant p65 protein (lanes 1 and 2). Purification is demonstrated as the p65 was detected in elute
fraction (lane 5) but not in wash fractions (lanes 3 and 4).
4.3 Cellular distribution of EGR-2 protein
In order to determine cellular distribution of the EGR-2 protein, Jurkat T cells were
transfected with EGR-2YFP expression plasmid and fluorescent microscopy analysis
(Zeiss CLSM) was performed. In unstimulated cells YFP tagged EGR-2 is localized
predominantly in the cytoplasm (80 %) (Fig. 11, panels I, III ). Upon PHA/PMA
stimulation, most of the protein translocates into the nucleus, and about 20 % of the
protein is cytoplasmic (Fig. 11, panels IV, VI). Thus, in stimulated Jurkat T cells about
80 % of the YFP tagged EGR-2 protein has nuclear localization while the rest is










Fig. 11: Localization of EGR-2 protein in unstimulated and stimulated Jurkat T cells.
Jurkat T cells were transiently transfected with EGR-2YFP and images were acquired under YFP filter
settings. In unstimulated cells EGR-2 shows predominantly cytoplasmic (I), and in stimulated cells
mainly nuclear localization (IV). Staining of DNA with DAPI indicates the nuclei of Jurkat T cells (II and
V). In Merge both filters are overlapped (III, VI).
Three dimensional images of EGR-2YFP expressing T cells confirm the cytoplasmic
localization of protein in unstimulated cells (Fig. 12).
Because in 3D pictures YFP signals overlap with those of DAPI (nucleus),
intracellular distribution of the protein is not visible. Therefore, spectral analysis
(Zeiss LSM “profile”) of the cell fluorescence in one confocal plane was performed, to
show the distribution of the proteins (Fig. 13). This approach shows the quantitative
distribution of the EGR-2 protein in the cell cytoplasm versus nucleus in unstimulated
Fig. 12: Localization of EGR-2YFP in
unstimulated Jurkat T cells (3D Image)
Jurkat T cells were transiently transfected
with EGR-2YFP. YFP signal shows the
cytoplasmic localization of EGR-2YFP.
Nuclear DNA is shown in blue (DAPI).
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(A) and stimulated (B) Jurkat T cells. In unstimulated cells (Fig. 13 A) 80 % of EGR-
2YFP protein is located in the cytoplasm, while in stimulated cells 80 – 90 % of the
protein is nuclear (Fig. 13 B).
Stimulated Jurkat cellsUnstimulated Jurkat cellsA B
Fig. 13: Distribution of EGR2YFP protein in unstimulated (A) and stimulated (B) Jurkat T cells.
Jurkat T cells were transiently transfected with EGR-2YFP. Diagrams show the distribution of EGR-2YFP
protein in the confocal plane marked with the red arrow. The yellow line in the graph represents
protein and the blue one DNA distribution.
Recombinant EGR-2 protein was expressed in human embryonic kidney 293 cells
and Sf9 insect cells. Additionally, microscopy analysis of cellular localization of the
EGR-2 protein in these expression systems was performed. HEK 293 cells were
transfected with EGR-2GFP expression vector and protein was detected mostly in the
nucleus (Fig. 14, I,III).
In immunefluorescence experiment insect Sf9 cells were infected with EGR-2
producing viruses. Specific EGR-2 antibody and fluorescently tagged secondary
antibody reveal mostly cytoplasmic localization of the protein in insect cells (Fig. 14,
IV, VI). Non-infected Sf9 cells treated under the same conditions show no signal,
which proves the specificity of the assay (data not shown).
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Fig.14: Localization of recombinant EGR-2 in HEK 293 and insect Sf9 cells.
HEK 293 cells were transiently transfected with EGR-2GFP and images were acquired under GFP filter
settings. EGR-2GFP protein shows mostly nuclear localization (I). In Sf9 cells, EGR-2 antibody shows
mostly cytoplasmic localization of EGR-2 protein (IV,VI). Staining of DNA with DAPI indicates the
nuclei of cells (II and V), while in Merge both filters are overlapped (III, VI).
4.4 Characterization of EGR-2/NF-κB interactions
EGR proteins interact with a number of transcription factors, such as NFAT and NF-
κB proteins, and regulate transcription of various inflammatory genes (Decker et al.,
2003, Wieland et al., submitted). In order to test whether EGR-2 interacts with NF-κB
transcription factors, pull down assays were performed, using recombinant and
native NF-κB proteins. In addition, in vivo interaction of these proteins was assayed
in FRET experiments. To elucidate the physiological function of these complexes,
transfection experiments were performed.
Results
51
4.4.1 Interaction of NF-κB with immobilized EGR-2 protein
The recombinant EGR-2 protein was expressed as histidine fusion protein and
immobilized on a nickel matrix (Fig. 15 A). To show the EGR-2/NF-κB interaction,
immobilized EGR-2 protein was incubated with recombinant p50 and p65 NF-κB
proteins. All protein fractions were assayed by SDS-PAGE and Western blotting. NF-
κB proteins are not detected in wash fractions (Fig. 15 B, lanes 3 and 4) but in the
elute fractions (Fig. 15 B, lanes 5 and 6), indicating complex formation of EGR-2 with
recombinant p50 and p65 NF-κB proteins.
Fig. 15: Interaction of recombinant EGR-2 with native and recombinant NF-?B proteins.
(A) Recombinant EGR-2 protein was coupled to the Ni-NTA matrix. Recombinant EGR-2 protein was
expressed in Sf9 cells and coupled to the Ni-NTA matrix. Several flow through and wash fractions
were obtained, separated by SDS-PAGE and analyzed by Western blotting. (B) Interaction between
EGR-2 and recombinant NF-κB proteins. Recombinant p50 and p65 proteins were incubated with
immobilized EGR-2. Several flow through and wash fractions were obtained, separated by SDS-PAGE
and analyzed by Western blotting. (C) Interaction between EGR-2 and native NF-κB proteins Native
p50, p65 and Rel B proteins from stimulated Jurkat T cell extract were incubated with immobilized
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In addition, binding of native p50, p65 and Rel B proteins to immobilized EGR-2 was
tested. Native p50, p65 and Rel B proteins from stimulated Jurkat cells were added
to the immobilized EGR-2 protein. Specific interaction was shown by detecting the
NF-κB proteins in the elute fractions (Fig. 15 C, lanes 5 and 6) while the wash
fractions contain no NF-κB proteins (Fig. 15 C, lanes 3 and 4). Thus, recombinant
p50 and p65 proteins as well as native proteins p50, p65 and Rel B interact with
EGR-2 and form stable complexes.
Interactions between EGR-2 and NF-κB proteins are specific because neither
recombinant nor native NF-κB proteins bind to the nickel matrix, in the absence of
EGR-2 (data not shown).
4.4.2 In vivo interaction of EGR-2 and NF-κB proteins
In order to investigate if EGR-2 and the NF-κB proteins form complexes in vivo,
FRET analysis was performed. FRET method allows detection of acceptor
fluorescence after donor excitation, when proteins are in very close proximity (about
6 to 10 nm) to each other. Jurkat T cells were transfected with EGR-2YFP and p50CFP
or EGR-2YFP and p65CFP plasmids. In transfected, and unstimulated cells EGR-2 is
predominantly localized in the cytoplasm (Fig. 16 A panels II, VI), while NF-κB
proteins show more even distribution in the cells (Fig. 16 A panels I, V). p50CFP and
p65CFP fluorescence were excited with a laser set to 458 nm. FRET signals were
detected in the YFP-channel. FRET signal is detected in both cell compartments, the
cytoplasm and nucleus, demonstrating complex formation between EGR-2 and p50
and p65 NF-κB proteins (Fig. 16 A panels III, VII). Transfection of an unrelated YFP
labeled protein did not result in a FRET signal (data not shown).
The specificity of FRET signal, and therefore the specificity of EGR-2YFP/p65CFP
protein-protein interaction was confirmed in ‘Acceptor Photobleaching’ experiment.
The region of interest (ROI, circled in red) was bleached using the laser set to YFP
filter setting at 100 % intensity. After acceptor bleaching no FRET signal was
detected (Fig. 16 B, panel III). The absence of the signal indicates that FRET signal
does not arise from the donor protein, but is the consequence of energy transfer from








Fig. 16 A: In vivo localization and interaction of EGR-2 and p50 or p65 NF-κB proteins in Jurkat
T cells.
Jurkat T cells were transiently transfected with EGR-2YFP and p50CFP or EGR-2YFP and p65CFP
expression vectors. EGR-2YFP images were acquired under YFP filter settings (II,VI) and p50 CFP and
p65CFP images under CFP filter settings  (I,V). FRET demonstrates the close proximity of co-transfected
proteins (III,VII). Merge shows overlapping of CFP, YFP and DAPI channels (IV, VIII).
p65CFP EGR-2YFP FRET MERGE
I II III IV
Fig. 16 B: The acceptor photobleaching of EGR-2YFP.
Binding of p65CFP and EGR-2YFPin the Jurkat T cells was confirmed with the acceptor ‚photobleaching‘.
One cell expressing EGR-2YFP was ‚bleached‘ (II, circled in red). Upon photobleaching of the
acceptor the fluorescence signal of the donor increases (I), as cross-talk of the proteins is eliminated.
The fluorescence signal of the acceptor (II), as well as the FRET signals (III) are abrogated.
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4.4.3 Functional interaction of EGR-2 and NF-κB proteins in regulation of
TNFa and ICAM-1 promoters
After having shown physical interaction of EGR-2 with p50 and p65 proteins of NF-κB
family, it was of interest to determine the functional relevance of these complexes.
Promoter regions of inflammatory genes TNFa and ICAM-1 contain EGR and NF-κB
binding sites (Manning and Rao, 1999, Maltzman et al., 1996). To elucidate the role
of EGR-2 and EGR-2/NF-κB complexes in transcriptional regulation of these pro-
inflammatory mediators, transient transfections were performed. HEK 293 cells were
cotransfected with EGR-2 and NF-κB expression plasmids and reporter plasmids
containing either TNFa or ICAM-1 promoter linked to the firefly luciferase gene.
Luciferase activity of reporter constructs harboring the TNFa or ICAM-1 promoters
was assayed. Used as single factors, EGR-2 and p50 had a little effect on
transcription, whereas p65 induced TNFa transcription 19-fold and ICAM-1
transcription 61-fold (Fig. 17 A, 17 B). The p50/p65 heterodimer induced transcription
of the same reporter genes 10.6- and 53.9-fold respectively. EGR-2 co-transfected
with p50 showed very low transcriptional activity, but EGR-2/p65 cotransfection
strongly induced expression of the TNFa (178-fold) and ICAM-1 promoters (127-fold)
(Fig. 17 A, 17 B).
Fig. 17: Functional interactions of EGR-2 and NF-κB proteins.
(A) HEK 293 cells were transfected with reporter construct containing wild type (-191 bp promoter
region) of human TNFα gene together with expression vectors coding for EGR-2, p50 and p65 NF-κB
proteins. (B) HEK 293 cells were transfected with the same expression vectors and reporter construct
containing wild type (-5800 bp promoter region) of human ICAM-1 gene. Each column represents the
mean value of five independent experiments and standard deviations are indicated. Binding sites of
TNFα and ICAM-1 reporter construct are shown in the graph below.
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These experiments demonstrate that the EGR-2/p65 heterodimer acts as a potent
activator of TNFa and ICAM-1 inflammatory gene transcription. Moreover,
transcriptional effect of EGR-2/p65 significantly enhances the effect of p50/p65
mediated activation of these inflammatory genes.
4.4.4 Functional interaction of EGR-1/p65, EGR-3/p65 and EGR-4/p65
heterodimers in regulation of TNFa and ICAM-1 promoters
To compare the transcriptional activities of the EGR family members transfection
assays were performed. HEK 293 cells were cotransfected with EGR-1, EGR-2,
EGR-3, EGR-4 and NF-κB p50 and p65 expression plasmids, and TNFa and ICAM-1
reporter constructs linked to the firefly luciferase gene. EGR-2/p65 complex showed
the highest level of transcriptional activity on TNFa promoter (178-fold) compared to
all EGR-/p65 heterodimers, whereas EGR-1/p65 complex was the strongest activator
of the ICAM-1 gene (147-fold) (Fig. 18 A, 18 B). These experiments demonstrate that
all four EGR zinc finger proteins show the similar cooperative effect with p65 protein
in activation of TNFa and ICAM-1.
Fig. 18: EGR-/p65 heterodimers are strong activators of TNFα and ICAM-1 gene transcription.
(A) HEK 293 cells were transfected with reporter construct containing wild type (-191 bp promoter
region) of human TNFα gene together with expression vectors coding for EGR-1, EGR-2, EGR-3,
EGR-4 and p50 and p65 NF-κB proteins. (B) HEK 293 cells were transfected with reporter construct
containing wild type (-5800 bp promoter region) of human ICAM-1 gene and the same expression
vectors. Each column represents the mean value of five independent experiments and standard
deviations are indicated. Binding sites of TNFα and ICAM-1 reporter construct are shown in the graph
below.

















































4.5 Expression and purification of NAB-2 protein
NAB-2 protein is a potent modulator of EGR mediated transcriptional activation
(Sevetson et al., 2000, Mechta-Grigoriou et al., 2000, Svaren et al., 1996). In order to
gain insight into interactions between NAB-2 and EGR family members, NAB-2 was
recombinantly expressed and used in protein binding assays. To investigate if native
NAB-2 protein synthesis is upregulated together with EGR-2 protein in vivo, Jurkat T
cells were stimulated and probed for expression of NAB-2.
Extracts prepared from PHA/PMA stimulated Jurkat T cells was separated by SDS-
PAGE and analyzed by Western blotting using a specific NAB-2 antibody. The
presence of the 70-72 kDa doublet was demonstrated (Fig. 19 A, lane 1), and trace
amounts of the protein were detected in extract prepared from unstimulated cells
(Fig. 19 A, lane 2).
The recombinant mouse NAB-2 was expressed as Flag fusion protein in HEK 293
cells. Cellular extract from transiently transfected cells was separated by SDS-PAGE
and again a 70-72 kDa doublet was identified by Western blotting (Fig. 19 B, lane 1).
The protein was not detected in extract prepared from untransfected HEK 293 cells
(Fig. 19 B, lane 2).
The NAB-2 protein was purified by immunoprecipitation. Recombinant NAB-2 protein
was bound to an anti-Flag matrix. After extensive washing protein was eluted by Flag
peptide. The detection of the protein in the cell extract and elute fractions confirms
the efficiency of the purification (Fig. 19 C, lanes 1-6).
Thus, recombinantly expressed NAB-2 protein showed the similar mobility as the
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Fig. 19: Expression and purification of NAB-2 protein.
(A) Expression of the native NAB-2 protein. NAB-2 protein is detected as 70-72 kDa doublet in extract
prepared from stimulated Jurkat T cells (lane 1). Protein is detected in trace amounts in extract
prepared from unstimulated cells (lane 2). (B) Expression of recombinant NAB-2 protein. The
recombinant NAB-2 was expressed in transiently transfected HEK 293 cells (lane 1) and was not
detected in extract from untransfected HEK 293 cells (lane 2). (C) Purification of NAB-2 protein.
Recombinant NAB-2 protein was immobilized to the αFlag matrix (lane 1-2). Purification is
demonstrated as the protein is present in the elute (lane 5), but absent in flow through or wash
fractions (lanes 2, 3 and 4).
4.6 Characterization of EGR-2/NAB interaction
In order to characterize physical and functional interactions between EGR-2 and
NAB-2 proteins several approaches were taken. Pull-down and co-
immunoprecipitation experiments were used to show physical binding of the
recombinant EGR-2 and NAB-2 proteins. FRET experiments examined complex
formation of proteins in vivo, and the physiological role of these proteins was
assayed in transfection experiments.
4.6.1 Interaction of EGR-2 with immobilized NAB-2 protein
To determine if EGR-2 forms physical complexes with NAB-2 proteins pull-down
assays were performed. Recombinant mouse Flag-tagged NAB-2 protein was
expressed and immobilized on an anti-Flag matrix and binding of recombinant EGR-2
was assayed. Cellular extracts, wash and elute fractions were collected, separated
by SDS-PAGE and analyzed by Western blotting using specific EGR-2 and anti-Flag
antibodies. NAB-2 was detected as 70-72 kDa doublet (Fig. 20 A lane 1) and
recombinant EGR-2 protein has a molecular mass of 55 kDa (Fig. 20 B, lane 1). The
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presence of NAB-2 and EGR-2 proteins in the elute fractions (Fig. 20 A, 20 B, lanes




























































Fig. 20: Interaction between EGR-2 and NAB-2 proteins.
(A) Recombinant NAB-2 protein was coupled to the anti Flag matrix. NAB-2 was recombinantly
expressed in HEK 293 cells and immobilized on the Flag matrix. The various extracts were separated
by SDS-PAGE and Western blotting. (B) Interaction between recombinant EGR-2 protein and NAB-2.
The recombinant EGR-2 protein was incubated with immobilized NAB-2. The various flow through,
wash and elute fractions were obtained and separated by SDS-PAGE and Western blotting.
4.6.2 Co-immunoprecipitation of EGR-2 and NAB-2 proteins
To ascertain that EGR-2 and NAB-2 proteins also form complexes in vivo, co-
immunoprecipitation analysis was performed. HEK 293 cells were cotransfected with
EGR-2GFP and Flag–tagged mouse NAB-2 expression plasmids. Flag-tagged NAB-2
protein was immunoprecipitated by anti-Flag antibody, as indicated by the presence
of the 70-72 kDa doublet in the eluate fractions (Fig. 21 A, lanes 5 and 6). EGR-2GFP
was detected in the cell extract (Fig. 21 B, lane 1) as a 72 kDa protein (molecular
weight of EGR-2 protein (55 kDa) plus GFP tag). The presence of EGR-2 in the
eluate (Fig. 21 B, lane 5) demonstrates interaction of EGR-2 with NAB-2. The
presence of the protein in the flow through and wash fractions (Fig. 21, lanes 2 and
3) shows saturation of the anti Flag antibody with NAB-2 protein. Specificity of
binding is confirmed by disability of the anti-Flag column to precipitate EGR-2GFP
alone (data not shown).
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Fig. 21: Co-immunoprecipitation of EGR-2 and NAB-2 proteins.
EGR-2GFP and NAB-2 expression plasmids were cotransfected in HEK 293 cells.(A) NAB-2 was
detected in the extract of transfected HEK 293 cells (lane 1). After incubation of the extract on the Flag
matrix, the matrix was washed and proteins eluted. All protein fractions were separated by SDS-PAGE
and analyzed by Western blotting. (B) EGR-2 was detected in extract from transfected HEK 293 cells
(lanes 1 and 2) and in the eluate with NAB-2 protein (lanes 5 and 6).
4.6.3 In vivo interaction of EGR-2 and NAB-2 proteins
In vivo interaction of EGR-2CFP and NAB-2YFP proteins was assayed by FRET
analysis. Jurkat T cells were cotransfected with fluorophore tagged EGR-2CFP and
NAB-2YFP expression plasmids. EGR-2CFP was localized mostly in the cytoplasm and
NAB-2YFP was predominantly located in the cell nucleus (Fig. 22). A fluorescence
energy transfer from donor to acceptor protein was detected in the YFP channel
upon excitation of EGR-2CFP with a laser set to 458 nm. A strong FRET signal was
detected in the cell nucleus.
The results of this in vivo experiment provide additional evidences of physical
interaction between EGR-2 and NAB-2 proteins. Binding was further confirmed with
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EGR-2CFP NAB-2YFP FRET MERGE
Fig. 22: In vivo localization and interaction of NAB-2YFP and EGR-2 CFP proteins in Jurkat T cells.
Jurkat T cells were transiently transfected with NABYFP and EGR-2 CFP expression vectors. The CFP
filter settings show the localization of EGR-2CFP (I), while YFP filter settings show the localization of
NAB-2YFP protein (II). FRET demonstrates the close localization of co-transfected proteins (III). Merge
shows overlapping of CFP, YFP and DAPI channels (IV).
4.6.4 Functional interaction of EGR-2 and NAB proteins in regulation of TNFa
and ICAM-1 promoters
Depending on the promoter context NAB proteins are described to act either as
repressors (PDGF, VEGF, HGF, TGF-ß1) or activators of transcription (LH ß, FasL)
(Houston et al., 2001, Svaren et al., 1998, Qu et al., 1998, Sevetson et al., 2000).
Therefore the effect of NAB proteins on transcriptional activity of the EGR-2/p65
complexes on two inflammatory gene promoters TNFa and ICAM-1 was studied.
HEK 293 cells were cotransfected with EGR-2, p65 and NAB-2 expression vectors
and either TNFa or ICAM-1 reporter constructs linked to the luciferase gene.
Luciferase activity of reporter constructs was assayed, and the results show that co-
expression of NAB-2 protein represses EGR-2/p65 mediated induction of both TNFa
and ICAM-1 reporter genes. Induction of TNFa promoter activity by EGR-2/p65 was
set to 100% and decreased by more then 98% upon coexpression of NAB-2 protein,
while EGR-2/p65 induction of ICAM-1 promoter decreased by 96% (Fig. 23 A, 23 B).
Additionally, the effect of NAB-1 on EGR-2/p65 mediated TNFa transcription was
assayed. EGR-2/p65 induced transcription of TNFa (100%) was reduced by NAB-1
expression by 99% (Fig. 24).
Thus, NAB-1 and NAB-2 proteins act as repressors of EGR-2 protein in regulating
TNFa and ICAM-1 gene transcription.
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Fig. 23: NAB-2 protein inhibits EGR-/p65 mediated activation of TNFα and ICAM-1 gene
promoters.
(A) HEK 293 cells were transfected with reporter construct containing wild type (-191 bp promoter
region) of human TNFα gene and expression vectors coding for EGR-, p65 NF-κB and NAB-2
proteins. (B) The effect of the same proteins was assayed on the wild type (-5800 bp promoter region)
of human ICAM-1 gene. Each column represents the mean value of five independent experiments and
standard deviations are indicated.
4.6.5 Functional interaction of EGR-1, EGR-3, EGR-4 and NAB proteins in
regulation of TNFa and ICAM-1 promoters
To compare the effect NAB proteins on transcription efficiency of other EGR proteins,
further transfection assays were performed. HEK 293 cells were cotransfected with
combinations of EGR-/p65 and NAB-1 or EGR-/p65 and NAB-2 expression plasmids
and TNFa or ICAM-1 reporter constructs. Co-expression of NAB-2 strongly
decreases EGR-1/p65, EGR-3/p65 and EGR-4/p65 mediated activation of both TNFa
and ICAM-1 promoters (95%-99%) (Fig. 23 A, 23 B). NAB-1 protein represses
transcriptional activity of all EGR-/p65 heterodimers on TNFa gene transcription by
99-99,5% (Fig. 24).
Thus, both NAB proteins act as repressors of EGR-/p65 mediated activation of TNFa
and ICAM-1 inflammatory genes.


































































Fig. 24: NAB 1 protein inhibits EGR/p65 mediated activation of TNFα gene promoter.
HEK 293 cells were transfected with reporter construct containing wild type (-191 bp promoter region)
of human TNFα gene together with expression vectors coding for EGR-, p65 and NAB-1 proteins.
Each column represents the mean value of five independent experiments and standard deviations are
indicated. Binding sites of TNF α reporter construct are shown in the graph below.
4.6.6 Localization of the interaction domains in the EGR-4 protein
The R1 repressor domain of EGR-1 protein was postulated as binding site for NAB
repressor proteins (Russo et al., 1993, Russo et al., 1995). A similar R1 domain of
EGR-4 protein shows a low homology to the same domain of other EGR family
members. In our experiments co-expression of EGR-4, p65 and NAB-2 resulted in a
strong decrease (94%) of wild type TNFa promoter activity.
To localize functional domains of EGR-4 responsible for NAB-2 binding, EGR-4
deletion mutants were used in cotransfection experiments: EGR-4-II, EGR-4-III,
EGR-4-VI, EGR-4-VII, EGR-4-VIII, EGR-4-IX, EGR-4-X and EGR-4-XI (Fig. 27 A).
Previous results show that all EGR-4 deletion mutants lacking R1 domain (III, IV,
VI,VII,VIII,IX, X, XI) induce the transcription of the pTZN3-Luc TNFa promoter when
co-transfected with p65 plasmid. EGR-4-XI mutant binds p65 and shows the highest
induction of pTZN3-Luc TNFa promoter (250-fold) (N. Nehmann, Doctoral thesis). Of
all deletion mutants tested, only EGR-4-II (aa 325-487) which contains both R1 and
zinc-finger domains did not increase TNFa transcription in synergy with p65.
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Co-expression of NAB-2 protein abolishes induction of all EGR-4 constructs lacking
R1 domain (III, IV, VI,VII,VIII,IX, X, XI), as well as with EGR-4-II mutant. (Fig. 27 B).
The presented results demonstrate that NAB-2 protein represses transcriptional
efficiency of all EGR-4 deletion mutants in combination with p65, to the extent similar
to the wild type EGR-4.
Fig. 27: NAB-2 protein represses mutant EGR-4/p65 mediated transcription of TNFα gene.
HEK 293 cells were transfected with expression vectors encoding truncated EGR-4 proteins, as
indicated, together with the expression vectors for p65, NAB-2 and the wild type (-191 bp promoter
region) TNF α reporter construct. Each column represents the mean value of five independent
experiments, and standard deviations are indicated.
4.7 Interaction of EGR-1, EGR-3 and EGR-4 proteins with NAB
Since NAB proteins repressed the transcriptional activity of all EGR proteins, as
demonstrated in the transfection assays, it was of interest to analyze if EGR proteins
form physical complexes with NAB-2 protein. Binding of recombinant EGR proteins to
immobilized NAB-2 was tested in ‘pull-down’ assay, and in vivo interaction between
EGR-4 and NAB-2 proteins was analyzed using FRET method.











































4.7.1 Interaction of recombinant EGR-1, EGR-3, EGR-4 proteins with
immobilized NAB-2
The recombinant mouse Flag tagged NAB-2 protein was coupled to the anti Flag
matrix (Fig. 25 A). The bound material was incubated with cellular extract containing
recombinant EGR-1. The matrix was washed and proteins eluted. All protein fractions
were analyzed by SDS-PAGE and Western blot, using specific anti Flag and anti
EGR-1 antibodies. Both proteins were detected in the eluate (Fig. 25 A, 25 B, lanes 5
and 6), which indicates direct physical interaction between EGR-1 and NAB-2
proteins.
The same experiment was performed using recombinant EGR-3 and EGR-4 proteins
(Fig. 25 C, 25 D). EGR proteins are present in the elute, but not in wash fractions
(Fig. 25 C, 25 D, lanes 3 and 4), thus demonstrating EGR-3/NAB-2 and EGR-4/NAB-
2 complex formation.
Fig. 25: Complex formation between NAB-2 and indicated EGR proteins.
(A) NAB-2 protein was coupled to the anti Flag matrix. NAB-2 was recombinantly expressed in HEK
293 cells (lanes 1), coupled to the anti Flag matrix (lane 2). The various wash and elute fractions were
separated by SDS-PAGE and analyzed by Western blotting. (B), (C), (D) Interaction of recombinant
EGR-1, EGR-3 and EGR-4 with immobilized NAB-2 protein. In each experiment single recombinant
EGR proteins were incubated with immobilized NAB-2 (lanes 1 and 2). The various flow through, wash
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4.7.2 In vivo interaction of EGR-4 and NAB-2 proteins
Complex formation between EGR-4 and NAB-2 proteins was confirmed in vivo, using
FRET experiment. EGR-4CFP and NAB-2YFP were cotransfected into Jurkat cells, and
upon expression, donor fluorescent protein (EGR-4CFP) was excited with a laser set
to 458 nm. FRET signals were detected in the YFP-channel of the META detector set
to 559 to 615 nm. FRET signal was detected in both cell compartments, the
cytoplasm and nucleus, demonstrating complex formation between EGR-4 and NAB
proteins (Fig. 26).
Fig. 26: In vivo localization and interaction of NAB-2YFP and EGR-4CFP proteins in Jurkat T cells.
Jurkat T cells were transiently transfected with NABYFP and EGR-4CFP expression vectors. The CFP
filter settings show the localization of EGR-4CFP (I), while YFP filter settings show the localization of
NAB-2YFP protein (II). FRET demonstrates the close localization of co-transfected proteins (III). Merge
shows overlapping of CFP, YFP and DAPI channels (IV).
4.8 Interaction of NAB-2 and p65 proteins
As NAB-2 repressed synergistic activity of wild type and mutant EGR-4/p65
complexes in activation of TNFa gene, we asked if NAB-2 protein specificity is
confined exclusively to EGR family members or includes p65 protein as well. Co-
transfection of HEK 293 cells with NAB-2 and p65 plasmids represses the activation
of TNFa promoter by 80% and co-expression of NAB-1 and p65 vectors leads to the
decrease of TNFa induction by 85% (Fig. 28). These results show that NAB proteins
also repress p65 induced activation of TNFa promoter.
EGR-4CFP NAB-2YFP FRET MERGE
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In order to investigate if p65 and NAB-2 form physical complexes, FRET analysis
was performed. Jurkat T cells were co-transfected with NAB-2YFP and p65CFP
expression plasmids. Both proteins are localized predominantly in the cytoplasm.
p65CFP fluorescence was excited with a laser set to 458 nm and FRET signals were
detected in the YFP-channel of the META detector set to 559 to 615 nm.
The detection of the FRET signal in the cell cytoplasm demonstrates complex
formation of NAB-2 and p65 proteins (Fig. 29).
NAB-2YFP FRET MERGEp65CFP
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Fig. 29: In vivo localization and interaction of NAB-2YFP and p65 CFP proteins in Jurkat T cells.
Jurkat T cells were transiently transfected with NABYFP and p65CFP expression vectors. The CFP filter
shows the localization of p65CFP (I), while YFP settings show the localization of NAB-2YFP (II). FRET
signal demonstrates the complex formation of co-transfected NAB-2YFP and p65CFP proteins (III).
Merge shows overlapping of CFP, YFP and DAPI channels (IV).
The NAB proteins are upregulated simultaneously with EGR-2 proteins in stimulated
Jurkat T cells (Fig. 19 A). Both protein form physical complexes, as demonstrated in
‘pull-down’ and co-immunoprecipitation assays. The strong FRET signal in EGR-2CFP
Fig. 28: Functional interaction of NAB and
p65 NF-κB proteins on TNFα gene
promoter.
HEK 293 cells were transfected with reporter
construct containing wild type (-191 bp
promoter region) of human TNFα gene
together with expression vectors coding for
the indicated NAB and p65 NF-κB proteins.
Each column represents the mean value of
five independent experiments and standard
deviations are indicated. Binding sites of TNF






















and NAB-2YFP co-transfected Jurkat T cells is detected in cell nuclei, indicating a role
these proteins have in transcriptional regulation (Fig. 22). The role of NAB proteins in
regulation of EGR mediated transcription was analyzed in transfection assays. Both
NAB-1 and NAB-2 proteins act as transcriptional repressors, abrogating the activity
of all four EGR-/p65 complexes on TNFa and ICAM-1 gene transcription (Fig. 23,
24). ‘Pull–down` and FRET assays additionally demonstrated physical interaction of
EGR-4 and NAB-2 proteins (Fig. 25, 26). This interaction was more closely
investigated in transfection assays with EGR-4 deletion mutants, p65 and NAB-2
(Fig. 27). NAB-2 represses the activity of all mutant EGR-4/p65 complexes on TNFa
promoter, indicating the ability of NAB-2 protein to bind not only EGR-4 but p65
protein as well. This hypothesis was confirmed in FRET and transfection assays,
where NAB-2 and p65 proteins were demonstrated to form functional and physical
complexes (Fig. 28, 29).
4.9 EGR-EGR interactions
EGR proteins interact with a number of general and specific transcription factors and
regulate transcription of numerous genes like cytokines, hormones and transcription
factors. To investigate if EGR proteins also form heterodimers, ‘pull-down’ assays
and FRET experiments were performed. Their functional role was addressed by
performing transfection assays.
4.9.1 Interactions of EGR-2, EGR-3 and EGR-4 with immobilized EGR-1 protein
In order to test if EGR proteins form heterodimers, ‘pull-down’ assays were
performed. Recombinant, histidine tagged, EGR-1 protein was attached to the nickel
matrix and binding of native, Jurkat cell derived EGR proteins was assayed.
All protein fractions were collected, separated by SDS-PAGE and analyzed by
Western blotting using specific antibodies. EGR-1 protein is detected in lysate and
elute fractions as a doublet of 72-80 kDa (Fig. 30 A, lanes 1, 5 and 6). Specific
attachment of the protein to the nickel matrix is observed as the protein is absent in
wash fractions (Fig. 30 A, lanes 3 and 4). EGR-2 protein was detected in Jurkat cell
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extract and elute fractions (Fig. 30 B, lanes 1, 5 and 6) but not in the flow through or
wash fractions (Fig. 30 B, lanes 2, 3 and 4), thus indicating specific binding of EGR-2
to EGR-1. Additionally, binding of native EGR-3 and EGR-4 proteins to EGR-1 was
assayed, and EGR-1/EGR-3 and EGR-1/EGR-4 complex formation was
demonstrated (Fig. 30 C and 30 D). To prove the specificity of EGR-EGR
interactions, Jurkat cell extract was directly bound to the nickel matrix. After
incubation, matrix with the bound material was washed and eluted. All fractions were
separated by SDS-PAGE and analyzed by Western blot. The absence of all native
EGR proteins in elute fractions shows that native EGR proteins do not bind to the
matrix and thus confirm the specificity of the observed interaction (data not shown).
The ‘pull-down’ assays demonstrated the formation of EGR-EGR protein complexes.
Fig. 30: Complex formation between recombinant EGR-1 and native EGR-2, EGR-3 and EGR-4
proteins
(A) EGR-1 protein was bound to Ni-NTA matrix. EGR-1 was recombinantly expressed in Sf9 cells and
immobilized on the Ni-NTA matrix. Various flow through, wash and elute fractions were obtained,
separated by SDS-PAGE and analyzed by Western blotting using specific EGR-1 antibody. (B), (C),
(D) Interaction of native EGR-2, EGR-3 and EGR-4 with immobilized EGR-1 protein. In each
experiment Jurkat cell extract was incubated with immobilized EGR-1 protein. Various protein fractions



































































4.9.2 In vivo interaction of EGR-EGR proteins
Formation of EGR/EGR complexes was further confirmed by fluorescence
microscopy. Jurkat T cells were transiently transfected with EGR-1CFP and EGR-2YFP,
EGR-3YFP and EGR-4YFP expression plasmids. EGR-1CFP signal is detected
predominantly in the nucleus, while EGR-2YFP has cytoplasmic localization (Fig. 31,
panels I, II). FRET signal shows the transfer of the energy from EGR-1CFP to EGR-
2YFP and this signal was localized predominantly in the cell nucleus (Fig. 31, panel
III). This signal demonstrates the close proximity and most likely interaction of the
two proteins in the cell. In the case of EGR-1/EGR-3YFP or EGR-1/ EGR-4YFP co-
transfection, EGR-3YFP and EGR-4YFP single signals are detected predominantly in the
cytoplasm (Fig. 31, panels VI, X). FRET signals are localized mostly in cell nuclei,
confirming the interaction of transfected proteins (Fig. 31, panels VII, XI)
Fig. 31: Complex formation between EGR-1 and EGR-2, EGR-3 and EGR-4 proteins in Jurkat T
cells.
EGR-1CFP and EGR-2YFP, EGR-3YFP, EGR-4YFP were co-transfected in Jurkat T cells as indicated. The
localization of EGR-2YFP, EGR-3YFP, EGR-4YFP is visible under the YFP filter settings (II,VI,X), while
CFP filter settings show the localization of EGR-1CFP (I,V, IX). FRET signal demonstrates close
proximity of co-transfected proteins (III,VII, XI). Merge shows overlapping of CFP, YFP and DAPI
channels (IV, VIII, XII).
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4.9.3 Functional interaction of EGR-EGR heterodimers in regulation of TNFa
and ICAM-1 promoters
In order to assay if EGR-EGR complexes have transcriptional activity, transfection
experiments were performed. HEK 293 cells were co-transfected with the
combination of EGR-1/EGR-2, EGR-1/EGR-3 or EGR-1/EGR-4 expression vectors
and luciferase activity of TNFa or ICAM-1 reporter constructs was assayed (Fig. 32
A, 32 B). Co-expression of EGR-EGR proteins showed 1-2 fold induction of both
reporter constructs, not enhancing the activity of the single EGR proteins.
Additionally, cotransfecting EGR-1/EGR-4/p65 expression vectors induces the
transcription of TNFa promoter 79.6-fold and ICAM-1 promoter 75.6-fold. This
transcriptional activity was reduced about 40-50 % as compared to the induction
obtained with the same promoters with EGR-1/p65 or EGR-4/p65 vectors.
Transfecting EGR-1/EGR-2/p65 or EGR-1/EGR-3/p65combinations of plasmids























































Fig. 32: Functional interaction of EGR and p65 NF-κB proteins on TNFα and ICAM-1 gene
promoters
(A) HEK 293 cells were transfected with reporter construct containing wild type (-191 bp promoter
region) of human TNFα gene together with expression vectors coding for the indicated EGR and p65
NF-κB proteins, or (B) wild type (-5800 bp promoter region) of ICAM-1 gene with the same expression
plasmids. Each column represents the mean value of five independent experiments and standard




Proteins of the EGR family are expressed in diverse immune cells and are induced
by different stimuli. During an inflammatory response, EGR proteins act as
transcriptional regulators and induce number of pro- and anti-inflammatory cytokines.
This cytokine gene transcription is regulated by interaction of EGR family members
with various general and regulatory transcription factors, such as members of the
NFAT and NF-κB protein family.
This work defines a role of EGR-2 transcription factor in TNFa and ICAM-1
inflammatory gene regulation. EGR-2 acts as strong transcriptional activator by
interacting with NF-κB p65 protein and induces transcription of TNFa and ICAM-1
genes. This strong cooperative effect of EGR-2/p65 heterodimers is downregulated
by the repressor proteins NAB-1 and NAB-2. Here I show that the two NAB proteins
interact with all members of EGR family and repress their transcriptional activity.
5.1 Expression and localization of EGR-2 protein
EGR proteins are transcription factors and belong to the group of ‘immediate early
proteins’. Four members of the EGR protein family are upregulated in various cells
directly upon stimulation, in the absence of ‘de novo’ protein synthesis. EGR-2
protein is detected as 55 kDa protein in Jurkat T cell extract, by means of Western
blotting, as early as 3 hours after stimulation (Fig. 7A). Faster migrating bands were
detected in the same extract and most likely represent EGR-2 degradation products.
The low expression levels and short half life of EGR-2 protein have been reported
(Vesque and Charnay, 1992, Nagarajan et al., Neuron, 2001). EGR-2 has a very
short half-life (20 min) in eucaryotic cells (Vesque and Charnay, 1992) and EGR-2
wild type protein showed decreased stability in comparison with various EGR-2
mutants (Nagarajan et al., Neuron, 2001).
EGR-2 protein was recombinantly expressed in order to perform in vitro binding
assays and to characterize its interaction with  partner proteins. Baculovirus
expression system was chosen for EGR-2 protein expression in Sf9 insect cells,
because post-translatory modifications which are essential for proper folding of the
protein, exist only in eucaryotic expression system. The recombinant EGR-2 protein
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shows a mobility of 55 kDa (Fig. 7 B), similar to the Jurkat derived protein. The
similar mobility was observed for its mouse homologue (Krox 20), obtained by
transient transfection of HEK 293 cells (Fig. 7 B). Due to the histidine tag human
recombinant EGR-2 was purified using nickel chelate chromatography (Fig. 9).
Mitogen activation of T cells initiates a MAP/ERK signaling cascade and triggers
EGR gene transcription (Kaufmann et al., 2001, Thiel et al., 2002). The novel EGR
transcripts are detected as early as 10 minutes after T cell receptor ligation, and their
induction does not require de novo protein synthesis. All four EGR gene transcripts
are simultaneously translated in the cytoplasm of stimulated T cells and subsequently
translocate to the nucleus, where they bind to promoter regions of their target genes
(Skerka et al., 1997). A detailed analysis of EGR-2 protein expression and
distribution in T cells has not been shown yet.
Cellular distribution of EGR-2 protein was therefore investigated in unstimulated and
stimulated Jurkat T cells. The cells were transfected with EGR-2YFP expression
plasmid and confocal fluorescence microscopy was performed. In unstimulated T
cells, EGR-2 protein is localized predominantly in the cytoplasm and about 20 % of
the protein is localized in the nucleus (Fig. 11). Upon PHA/PMA stimulation, EGR-2
protein is detected predominantly in the nucleus (Fig. 11). The profiles of protein
distribution in one confocal plane of stimulated and unstimulated Jurkat T cells show
that in unstimulated cells (Fig. 13) 80 % of EGR-2 protein is localized in the
cytoplasm, while in stimulated cells 80 – 90 % of the protein is nuclear. That indicates
translocation of the EGR-2 protein from the cytoplasm to the nucleus upon mitogen
stimulation of the cells. SDS-PAGE and Western blot analysis of stimulated Jurkat T
cell cytoplasmic and nuclear extracts showed mostly nuclear presence of
endogenous EGR-2 protein (data not shown), what underlines the result obtained in
microscopy analysis.
Thus, EGR-2 protein localization in Jurkat T cells was analyzed by confocal
fluorescence microscopy and biochemical methods. EGR-2 is localized in the
cytoplasm of the resting cells, and has nuclear localization stimulated cells.
EGR-2 protein distribution was further analyzed in Sf9 insect and human 293 kidney
cells. Overexpression of fluorescent EGR-2GFP in HEK 293 cells shows mostly
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nuclear localization of the protein (Fig. 14), which correlates with the high
transcriptional activity of these cells.
In contrast, in insect cells EGR-2 protein is detected predominantly in the cytoplasm
(Fig. 14). The cytoplasmic localization of EGR-2 protein in Sf9 cells is explained by
the fact that expression using recombinant viruses generates unphysiologically high
concentrations of the protein in the cell. This leads to the inefficient nuclear
translocation and accounts for the presence of the EGR-2 protein in the cytoplasm.
Distribution of the proteins depends therefore on the protein expression rate, as seen
in the confocal fluorescent microscopy (Fig. 14). The infection of Sf9 cells with EGR-
2 recombinant viruses is more efficient then transfection of HEK 293 cells with EGR-
2 plasmids, and consequently the expression rates of protein are much higher.
In conclusion, EGR-2 protein is detected mostly in the cytoplasm of transfected
Jurkat T cells, and upon stimulation the protein translocates to the nucleus, to the site
of gene transcription. In Sf9 cells EGR-2 protein is predominantly in the cytoplasm,
and in HEK 293 cells it has nuclear localization.
5.2 Interaction of EGR-2 with NF-κB proteins
One of the major questions in eucaryotic gene transcription is how is the specificity in
gene activation achieved? A wide variety of transcription factors are simultaneously
activated by mitogenic growth factors, differentiating factors or various environmental
insults. The newly translated factors are translocated to the nucleus and bind to
regulatory sequences in the promoter regions of large number of genes. However, a
specific subset of transcription factors will be actually activated in response to a
particular stimulus and will bind to various gene promoters. The nature of the
stimulus, its strength and duration, the cell type and the number of surface receptors
play a vital role in signaling transduction and activation of the specific transcription
factors. Further on, the specificity of these factors is increased by co-operation with
other nuclear factors, to ensure regulation of gene expression in a selective manner.
To get a better insight in transcriptional role of EGR-2 proteins, I asked if EGR-2
forms functional complexes with proteins of the NF-κB family.
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5.2.1 Expression and localization of NF-κB proteins
Native NF-κB proteins were expressed in stimulated Jurkat T cells, and as
recombinant proteins as GST fusion proteins in E. coli. p50 was detected as 50 kDa
protein, while p65 and Rel B have molecular masses of 65 kDa and 69 kDa
respectively (Fig. 8). Both endogenous and GST tagged recombinant proteins have a
similar mobility, which is explained by post-translational modifications of endogenous
proteins. Recombinant p50 and p65 NF-κB proteins were purified by GST affinity
chromatography (Fig. 10 A, 10. B).
Cellular distribution of NF-κB proteins was investigated using confocal fluorescence
microscopy. Jurkat T cells were transfected with p50CFP and p65CFP expression
plasmids, and fluorescence pattern of fluorophore tagged proteins was investigated.
Proteins are detected in both cellular compartments, but are predominant in the
cytoplasm (Fig. 16 A). This, mainly cytoplasmic localization of NF-κB proteins in
unstimulated cells, corresponds with previous reports (Liou, H.S. and Hsia, 2003,
May and Ghosh, 1998, Makarov S., 2000). NF-κB proteins belong to the family of Rel
transcription factors that are retained in the cytoplasm by an inhibitor protein IκB.
Stimulation of cells leads to a rapid degradation of IκB and the release of active NF-
κB which translocates into the nucleus.
Having shown that EGR-2 protein also has a nuclear localization in stimulated Jurkat
T cells, it was of interest to investigate if EGR-2 and NF-κB proteins form physical
and functional complexes.
5.2.2 Interaction of EGR-2 with NF-κB
This work shows that EGR-2 protein forms physical complexes with proteins of NF-
κB family. The association between EGR-2 and p50 and p65 NF-κB proteins is
demonstrated in vitro by ‘pull-down’ assays, and in vivo by FRET analysis. The




In vitro ‘pull-down’ assays demonstrate binding of recombinant NF-κB proteins p50
and p65 to immobilized EGR-2 (Fig. 15 B). EGR-2 was recovered in the elute
together with p50 and p65, indicating complex formation of the proteins. Native,
Jurkat derived p50, p65 and Rel B proteins also bind to the immobilized EGR-2 (Fig.
15 C), confirming the formation of EGR-2/p50, EGR-2/p65 and EGR-2/Rel B
heterodimers. EGR-2/NF-κB complex formation was also demonstrated by in vivo
FRET analysis. Upon cotransfection of EGR-2YFP and p50CFP or EGR-2YFP and
p65CFP expression plasmids into Jurkat T cells, FRET analysis was performed. A
FRET signal is detected in the acceptor filter set, after donor fluorophore excitation,
indicating close proximity of proteins (< 10nm) (Fig. 16 A). FRET signal is detected
predominantly in the nuclei of transfected cells, where transcriptional regulation takes
place. The specificity of EGR-2/NF-κB interactions was confirmed in the method of
acceptor ‘photobleaching’. Inactivation of the acceptor (EGR-2YFP) by photobleaching
(Fig. 16 B, panel II) resulted in a significant increase of donor fluorescence (p65CFP)
(Fig. 16 B, panel I). At the same time, the FRET signal is absent (Fig .16 B, panel III),
as the cross talk between proteins is eliminated.
Thus, detecting the FRET signal in cell nuclei demonstrates close proximity of EGR-
2YFP and p65CFP proteins, and the specificity of interaction is confirmed by acceptor
photobleaching.
Defining the interaction domains of EGR proteins specific for binding to p65 activator
protein, and resolving the details of these interactions is of basic interest. The third
zinc finger domain of EGR-4 protein is responsible for p65 binding (Wieland et al.,
submitted). Considering this result and high amino acid homology in the zinc finger
region of all EGR proteins (Fig. 33), the zinc finger region of EGR-2 was
hypothesized to be responsible for p65 binding. In order to prove this hypothesis and
localize amino acids relevant for this interaction, `Peptide spot’ analysis was
performed (N. Nehmann, Doctoral Thesis). Peptides representing EGR-2 zinc-finger
region were synthesized, immobilized on a membrane and incubated with p65
proteins. The experiment shows that binding of p65 takes place weakly in the first (aa
349-370) and strongly in the third zinc finger (aa 406-426) of EGR-2. Similarly, it was
recently reported that the zinc finger region of EGR-1 protein is responsible for
interactions with p65 (Chapman and Perkins, 2000). Also, the zinc finger region of
Sp1, another zinc finger family member, shows the same specificity in its interaction
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with p65 (Perkins et al., 1994) as well as with other Rel proteins – c-Rel, Rel A, p50,
p52 and v-Rel (Sif and Gilmore, 1994).
This work presents evidence of EGR-2 and NF-κB protein complex formation. EGR-2
interacts with p50 and p65 proteins, as demonstrated in vitro ‘pull-down’ assays, and
in vivo using FRET and acceptor ‘photobleaching’ analysis. The zinc finger region of





Fig. 33: Alignment of amino acids of the third zinc finger region of EGR-1 to EGR-4 proteins.
Positively charged amino acids which mediate the interaction with p65 are shown in blue. Yellow color
marks the conserved cysteine and histidine residues which form the zinc finger structure.
TNFa and ICAM-1 cytokines are important inflammatory mediators, and their
promoter regions contain both EGR and NF-κB binding sites (Krämer et al.,1994,
Tsai et al., van der Stolpe and Saag, 1996). To test if EGR-2/NF-κB complexes play
a role in transcriptional regulation of TNFa and ICAM-1 genes, co-transfection assays
were performed. EGR-2/p65 strongly induces transcription of both TNFa (178-fold)
and ICAM-1 inflammatory genes (127-fold). However, EGR-2/p50 complex represses
the transcription of the same genes (Fig. 17. A, 17. B), thus demonstrating the
specificity of these complexes in gene regulation.
Transcription of inflammatory genes is regulated by NF-κB proteins, especially the
classical NF-κB complex (Baldwin, A., 1996, Manning and Rao, 1999). Therefore it is
of interest to see that EGR-2/p65 complex exceeds the activity of NF-κB homo- and
heterodimers in activation of inflammatory gene transcription.
Further transfection assays demonstrated that all four EGR zinc finger proteins show
similar cooperative effect with p65 in TNFa and ICAM-1 gene transcription. EGR-
2/p65 showed the strongest potency in activation of TNFa promoter (178-fold
induction), compared to EGR-1/p65, EGR-3/p65 and EGR-4/p65 heterodimers (Fig.
18 A). ICAM-1 gene transcription is regulated by all EGR-/p65 heterodimers, and
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EGR-1/p65 complex exhibits strongest transcriptional activity (147-fold induction)
(Fig. 18 B).
Transcriptional regulation of the cytokine IL-2 and TNFa, is under positive control by
EGR-3/p65 and EGR-4/p65 complexes (Wieland et al., submitted). EGR-1/Rel A
synergy is vital for induction of NF-κB1 (p105) gene transcription (Cogswell et al.,
1997) and is required for maximal expression of the ICAM-1 gene (Maltzman et al.,
1996). These reports underline the importance of EGR/NF-κB protein interactions in
regulation of inflammatory gene transcription.
EGR proteins regulate gene transcription by interacting with various nuclear factors.
In addition to complex formation between EGR and specific transcription factors,
EGR-1, murine EGR-2 and p65 interact with basal factors such as CBP (cAMP
response element binding protein binding protein) and p300 (Gerritsen et al., 1997,
Silverman et al., 1998, Ainbinder et al., 2002, Luciano et al., 2003). Both EGR-1 and
p65 interact with TATA-box associated factors (TAF II 105) and histone
acetyltransferase (HAT) (Zhong et al., 1998, Zhong et al., 2000, Yamit-Hezi et al.,
1998). CBP engagement and HAT activity may be generally required for NF-κB
dependent promoter activation (Berghe et al., 1999).
CBP and p300 are cofactors that function as transcriptional integrators. These
cofactors interact with inducible and basal transcription factors and assembly of such
transcriptional complex marks the initiation of gene transcription. Such an
enhancer/transcription factor complex, or enhanceosome is shown to be inducer
specific (Tsytsykova et al., 2002, Barthel et al., 2003). Assembly of an inducer
specific enhanceosome might explain the redundancy of EGR proteins seen in the
transfection experiments. Even though all EGR proteins bind p65 and regulate
transcription of ICAM-1 and TNFa promoters, additional transcription factors may be
recruited to these promoters in vivo, depending on the actual stimulus. Additionally,
competition for limiting amounts of CBP/p300 by different transcription factors,
activated by diverse signaling pathways, may cause specific cellular responses to
appropriate signals (Gerritsen et al., 1997).
Further studies are needed to determine which additional specific and general
transcription factors interact with EGR and NF-κB proteins during stimulation of IL-2,
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ICAM-1 and TNFa inflammatory gene transcription. EGR and NF-κB transcription
factors, that showed a strong potency in inflammatory gene activation, represent
ideal targets for the development of inhibitors of the immune reactions.
5.3 Interaction of EGR- and NAB proteins
NAB proteins were originally described as EGR-1 protein repressors that regulate the
expression of a number of EGR-1 target genes including PDGF isoforms, VEGF,
HGF (Houston et al., 2001), TGF-ß1, MMP-3 (Qu et al., 1998) and bFGF (Svaren
et al. 1998). This work shows that NAB proteins downregulate transcription of TNFa
and ICAM-1 genes and presents the evidence for physical interactions between
NAB-2 and each of EGR proteins. Physical interactions of NAB-2 with each of the
EGR proteins are demonstrated in ‘pull-down’ assays, coimmunoprecipitation and
FRET experiments. In addition the physiological relevance of these interactions was
assayed in transfection experiments.
In vitro ‘pull-down’ assay demonstrates interaction between EGR-2 and NAB-2
proteins. Recombinant NAB-2 protein was immobilized to the anti-Flag matrix, and
incubated with EGR-2 protein. Detection of both proteins in the eluate demonstrates
specific binding of two proteins (Fig. 20). The in vitro co-immunoprecipitation
experiment confirms the interaction between recombinant EGR-2 and NAB-2 proteins
(Fig. 21). Binding of EGR-2 and NAB-2 proteins was also demonstrated by in vivo
FRET analysis in Jurkat T cells. A FRET signal, detected mainly in the cell nucleus,
indicates energy transfer from NAB-2 donor to EGR-2 acceptor protein that are
localized in close proximity (Fig. 22). As EGR-2 and p65 proteins also form
complexes in the cell nuclei, it is very likely that NAB-2 protein binds to the
transcriptional active EGR-2/p65 complex and regulates its activity. NAB-2 protein
also binds to EGR-1, EGR-3 and EGR-4 proteins, as demonstrated in ‘pull-down’
assays (Fig. 25). Thus, the ‘pull-down’ assays and FRET analysis present evidence
for physical interaction between NAB-2 and EGR proteins.
Depending on the promoter context, NAB proteins can act either as repressors or
activators of EGR mediated transcription. Both NAB-1 and NAB-2 proteins activate
Discussion
79
transcription of the EGR regulated LHß and Fas ligand promoters (Mittelstadt et al.,
1998, Mittelstadt et al., 1999, Sevetson et al., 2000). The analysis of LHß and Fas
ligand promoters demonstrated that both the nature and the number of EGR binding
sites in a promoter ultimately determine NAB function.
To assess the effects of NAB-1 and NAB-2 proteins on EGR-2/p65 mediated
transcription of TNFa and ICAM-1 genes, transfection assays were performed.
EGR-2/p65 mediated activation of TNFa promoter was repressed by 99% by NAB-1
and 98% by NAB-2 (Fig. 24, 23 A). In addition, EGR-2/p65 regulated ICAM gene
transcription is repressed to the similar extent by NAB-2 protein (Fig. 23 B).
Synergistic activity of EGR-1/p65, EGR-3/p65 and EGR-4/p65 complexes in
transcriptional activation of TNFa and ICAM-1 genes was equally abrogated upon
coexpression of NAB proteins. These results show that NAB proteins act as
transcriptional repressors of EGR-/p65 mediated activation of TNFa and ICAM-1
genes.
5.3.1 Interaction of EGR-4 with NAB proteins
NAB proteins downregulate the activity of EGR-1, EGR-2 and EGR-3 proteins that
contain conserved domain termed R1 (Russo et al., 1995, Swirnoff et al., 1998). The
absence of this conserved domain in EGR-4 protein was suggested as an inability to
bind NAB proteins (Russo et al., 1995).
R1 repressor domains of EGR proteins are shown in Fig. 34. Sequence alignment of
human EGR-1, EGR-2, EGR-3 and EGR-4 proteins shows the existence of
conserved amino acids within R1 repressor domain in EGR-1, EGR-2 and EGR-3
proteins, that are lacking in EGR-4 (Fig. 34). Transfection assays using wild type and
deletion mutants of EGR-1 and EGR-2 proteins demonstrated the role of R1 domain
in NAB protein binding (Russo et al., 1993, Svaren et al., 1996). Complete deletion of
R1 domain of EGR-1 protein, or single Ile – Phe mutation at residue 293 increases
protein’s transcriptional activity and demonstrates the importance of this domain for
NAB protein repressor binding (Russo et al., 1993). An I268N point mutation located
in R1 domain of EGR-2 is detected in the patient suffering from congenital
hypomyelinating neuropathy (CHN). This mutation also interrupts binding of NAB
proteins to EGR-2 and therefore confirms the significance of this conserved amino
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acid (Warner et al., 1999, Venken et al., 2002). These reports lead to the conclusion
that EGR-4 does not interact with NAB proteins. However, transfection assays
performed in this work show that both NAB proteins repress EGR-4/p65 mediated





Fig. 34: Alignment of R1 domain residues of the EGR proteins
R1 repressor domains of human EGR-1, EGR-2, EGR-3 and EGR-4 proteins are shown. Identical
residues in at least two proteins are colored. Arrowhead marks the position of the conserved Ile amino
acid in EGR 1-3 proteins, which is absent in EGR-4.
To determine if NAB-2 and EGR-4 proteins form physical complexes, pull down
assays were performed. The presence of both proteins in eluate demonstrated the
direct physical interaction between these two proteins (Fig. 25 A, 25. D). This binding
was further confirmed in FRET assay. Jurkat T cells were co-transfected with
fluorescently tagged NAB-2 and EGR-4 expression plasmids, and the presence of
FRET signal indicates complex formation between the EGR-4 and NAB-2 (Fig. 26).
In order to determine the importance of the EGR-4 R1-like domain for NAB binding,
various EGR-4 deletion mutants, p65 and NAB-2 expression plasmids were used in
transfection assays. All EGR-4 deletion mutants contain the zinc finger domain and
they interact with p65 NF-κB protein activating the transcription of TNFα (N.
Nehmann, Doctoral thesis). Deletion mutants III, VI, VII, VIII, IX, X and XI lack R1-like
domain. However, NAB-2 co-expression totally abolished transcriptional activity of all
mutant EGR-4/p65 complexes (Fig. 27). These results indicate that transcriptional
activity of TNFα is downregulated through interaction of NAB-2 protein with zinc
finger region of EGR-4, rather then with R1 domain. The abrogation of TNFα
transcription can also be a consequence of NAB-2 and p65 protein interaction. These
results point out that NAB-2 breaks up the interaction between EGR-4 and p65 by
binding simultaneously to both proteins in this complex.
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In conclusion, the transfection assays show that NAB proteins act as transcriptional
repressors of EGR mediated activation of TNFα and ICAM-1 genes. Direct physical
interactions between NAB-2 and all EGR proteins were demonstrated in ‘pull-down’
assays. Binding of EGR-2 and NAB-2 proteins was confirmed by in vivo FRET
analysis. This work shows for the first time that EGR-4 and NAB proteins form
functional and physical complexes.
5.3.2 Interaction of NAB and p65 proteins
To test the hypothesis that NAB proteins form physical and functional complexes with
p65 NF-κB protein, FRET analysis and transfection assays were performed. FRET
experiments demonstrated the existence of physical complexes between NAB-2 and
p65 proteins, localized mainly in the cytoplasm (Fig. 29). In transfection assays, p65
mediated activation of the TNFa promoter was repressed by 85 % by NAB-1 and
80 % by NAB-2 proteins (Fig. 28).
These results show that NAB-2 forms physical and functional complexes not only
with EGR family members but with p65 NF-κB proteins as well. As the NAB proteins
were previously described as EGR protein specific, this is the first evidence of direct
interaction of NAB proteins with the protein outside EGR family.
Direct tethering of NAB proteins by fusion to Gal4 DNA-binding domain represses
various Gal-4-repressive promoters in the absence of EGR proteins (Swirnoff et al.,
1998). A number of fusion proteins of R1 repression domain and various activator
proteins (other then EGR proteins) are inhibited by NAB-1 (Swirnoff et al., 1998).
NAB-1 has been suggested to target the basal transcriptional initiation complex and
the chromatin structure to repress transcription (Thiel et al., 2000).These
experiments and transfection assays presented in this work confirm that NAB
proteins are not activator–protein specific. They rather function as direct repressors,
interfering with the assembly or function of the basic transcriptional complex.
Due to the lack of a DNA-binding domain, NAB proteins necessarily require
interaction with DNA binding protein for proper function. Therefore I propose the
model in which NAB proteins are brought to the TNF α gene promoter by binding to
either p65 or to EGR proteins.
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Downregulation of p65 activity by NAB protein might also have an impact on all NF-
κB regulated genes. As NF-κB proteins play a major role in regulation of a number of
cytokine genes, NAB proteins may function as general repressors of inflammatory
reactions.
5.4 EGR-EGR complexes
EGR transcription factors are expressed in different tissues, where these proteins
interact with a number of specific and general transcription factors in regulating
transcription of various genes. In T lymphocytes EGR proteins interact with NFAT,
Sp1 and NF-κB proteins (Decker et al., 2003, Srivastava et al., 1998, Wieland et al.,
submitted). Western blot analysis of Jurkat T cell derived EGR proteins demonstrate
the appearance of high molecular weight bands (data not shown) which indicate that
EGR- proteins can form mono- or heterodimeric complexes.
This work shows for the first time that EGR proteins bind to each other and form
heterodimer complexes. ‘Pull-down’ assays and in vivo FRET analysis demonstrate
EGR-1/EGR-2, EGR-1/EGR-3 and EGR-1/EGR-4 complex formations, and
transfection assays were performed in order to explain their functional significance.
In the ‘pull-down’ assays recombinant EGR-1 protein was immobilized to the matrix,
and detected as a 72-80 kDa doublet in the lysate and eluate, but was absent in
wash fractions (Fig. 30 A). The doublet most likely represents phosphorylated and
non-phosphorylated proteins that have different mobilities. Different degrees of
phosphorylation has been shown previously for EGR-1 protein (Lemaire et al., 1990),
and is predicted for other EGR proteins, based on their high serine/threonine
contents. Detection of EGRs as several band proteins could also be a consequence
of differential splicing, as already shown for EGR-1 (Huang and Adamson, 1994 )
and EGR-2 (Chavrier et al., 1989, Vesque and Charnay, 1992). Native EGR-2, EGR-
3 and EGR-4 proteins are also detected in the eluate after incubation with the
immobilized recombinant EGR-1, which indicates complex formation of proteins (Fig.
30 B, 30 C, 30 D).
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In vivo binding of EGR proteins is demonstrated by confocal microscopy analysis.
EGR-1 was expressed as CFP fusion protein, and EGR-2, EGR-3 and EGR-4 as
YFP fusion proteins in Jurkat T cells. All proteins were detected in both cellular
compartments, but formation of the protein-protein complexes (FRET) was observed
predominantly in the cell nucleus (Fig. 31).
To determine if EGR-EGR heterodimers play a role in the transcriptional regulation of
inflammatory genes TNFa and ICAM-1, transfection assays were performed (Fig.
32). Coexpression of EGR-1/EGR-2, EGR-1/EGR-3 and EGR-1/EGR-4 protein
combinations showed a very little transcriptional activity of either promoters.
Similarly, the coexpression of EGR heterodimers together with NF-κB p65 did not
enhance the effect of EGR-/p65 heterodimers alone. When a combination of two
EGR proteins was coexpressed together with p65 proteins, a decrease of 40-50% in
promoter activation is observed, in comparison with EGR-/p65 transfections (Fig. 32).
In conclusion, EGR-EGR heterodimers alone show very little effect on transcription of
TNFa and ICAM-1 genes. The decrease in promoter activity upon cotransfection of
EGR-/EGR-/p65 results from the decrease in concentration of p65 DNA used for
triple transfections.
Concerning that EGR-EGR heterodimers do not activate transcription of TNFa and
ICAM-1 genes, it is of great interest to test other gene promoters for their
responsiveness to EGR-EGR heterodimers. Should EGR-EGR complexes have no
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